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INTRODUCTION 
CYSTIC FIBROSIS: GENERAL FEATURES 
Cystic fibrosis (CF) is the most common single gene disorder in The Netherlands and occurs 
approximately once in every 3600 children born alive (1). The heterozygous carrier frequency 
has been estimated to be approximately 1 :30. 
The defective gene was identified in 1989 and appeared to be located on chromosome 7. 
It codes for the cystic fibrosis transmembrane conductance regulator (CFTR), which acts as 
a transmembrane chloride channel. The most frequent mutation of this gene is the deletion of 
phenylalanine at position 508 ("F508). Almost 60% of the known CF patients in The 
Netherlands are homozygous for the "F508 mutation (2). More than 700 additional CFTR 
mutations related to CF have been identified as oflate May 1997 by the CF Genetic Analysis 
Consortium (3). 
The gene defect results in significant morbidity and affects mainly the respiratory tract and 
the pancreas. The CF lung presents an unique environment to microbial pathogens. The 
combination oflow or absent chloride secretion and an increased sodium absorption results in 
relative dehydration of the ainvays. Consequently, the disease is characterized by the 
production of abnonnally viscid secretions in epithelial tissues. Mucociliary clearance of 
bacteria from the lungs is impaired because of the viscid, dehydrated nature of the airway 
epithelia. Chronic ainvay inflammation leads to excessive secretion of purulent mucus and to 
obstmction of the airway which in turn causes bronchiectasis, pulmonary hypertension with 
cor pulmonale, haemoptysis, pneumothorax and, finally, respiratory failure. The exacerbation 
of puhnonary infections is the major cause of morbidity and mortality in patients with CF. 
Aggressive early treatment of respiratory infections is a critical success factor in the treatment 
ofCF patients. Thirty years ago, most patients died in infancy. Nowadays, patients born in the 
1990's are likely to live up to a median age of 40 years (4). 
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COLONIZATION OF THE RESPIRATORY TRACT 
Ordinarily, CF patients are colonized by and sometimes infected with a variety of potential 
microbial pathogens, almost any of which can cause serious lung infections. The respiratOlY 
pathogens most commonly isolated include Staphylococcus aureus, non-encapsulated 
Haemophillis influenzae and Pseudomonas aerugillosa. S. aUl'eliS and non-encapsu1ated H. 
ilif/llel/zae are isolated early in life. Later in life, nearly all CF patients become infected with 
P. ael"llgil/osa. In a recent study 81 % of all CF lung infections in adults appeared to caused by 
P. aerugil/osa, with only 30% attributable to S. allrells and 8% to H. ilif/llel/zae, the most 
common childhood infective pathogens (5). The species P. ael"llgil/osa is known for its 
extraordinary metabolic and genetic versatility resulting in the production ofmulliple vimlence 
factors. The species can become very easily resistant to many commonly used antibiotics. 
Eradication of P. aerugil/osa from the respiratory tract of CF patient is virtually impossible, 
and many patients harbor the organisms as their dominant respiratory pathogen for many years. 
A major factor which is responsible for the long-tenn persistence of P. aerllgil/osa in the lung 
is the bacterium's switch to the mucoid phenotype (6). Most patients are colonized with a llon-
mucoid phenotype in the beginning. The timing and causes ofthe mucoid switch are presently 
unknown. When the P. aeruginosa strain produces an alginate capsule or mucoid 
exopolysaccharide (MEP) and thus attains a mucoid phenotype, this is associated with a 
progressive decline in pulmonary function ofthe CF patients (6). CF patients who harbor non-
mucoid P. aerugillosa and / or harbor only S. aurells maintain over 90% oftheir expected lung 
function for many years. The presence of S. aUl'eliS in the absence of mucoid P. aeruginosa at 
the age of 18 correlates with long-teml survival of CF patients (7). The presence of slow-
growing subpopulations of S. aureus and P. ae/"llgillosa (tenned small colony variants or 
SCVs) has recently been associated with CF (8, 9). The SCV S. allrells and P. aerllgillosa can 
be cultured after exposure in vivo to aminoglycosides and exhibit decreased susceptibility 
against antimicrobial agents. 
Other bacterial pathogens cultured from the CF respiratory tract are generally not persistent 
colonizers; these intermittent species include Streptococcus plleumolliae, Escherichia coli, 
Klebsiella spp, Protells spp, Serratia spp, Elllerobacter spp, Citrobacter spp and group A 
streptococci (10). Many other species belonging to the group of gram-negative non-fennenters 
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have been isolated from the respiratory tract of CF patients, including Pseudomollas spp, 
Acilletobacler allitratus, Achrolllobacter spp, Stellotrophomonas maltophilia and Burkholderia 
cepacia « I0). Less often and later on in life, CF patients can become infected with organisms 
like Aspergillus spp, Candida a/hieans and atypical mycobacteria. Colonization of the 
previously mentioned microorganisms is intercurrent and is not associated with apparent 
clinical deterioration, with the exception of B. cepacia. The clinical course of patients 
following B. cepacia colonization and infection is variable. Of particular concern is a subset 
of patients who experience an acute syndrome, usually ending in death, characterized by severe 
and unexpected puhuonary complications (6). The prevalence of B. cepacia in The Netherlands 
is estimated to be less than 3% (11). 
DETECTION OF MICROORGANISMS IN THE RESPIRATORY TRACT OF CF 
PATIENTS 
In the clinical situation sputum ofCF patients produced during coughing is routinely cultured. 
Washed sputum specimens should be plated onto several media including Columbia agar 
containing 5% sheep blood, MacCoukey agar and chocolate agar. Additional selective media 
are used to isolate a specific microorganism despite the presence oflarge numbers of bacterial 
ceHs belonging to other species, for instance P. aerugillosa. Mannitol salt agar is a selective 
medium for S. aureus and it is used because the growth and detection of S. aureus may 
otherwise be hampered by the presence of mucoid P. aeruginosa (12). Thymidine-dependent 
S. aureus. which may appear during treatment with trimethoprim-sulfamethoxazole, are also 
able to grow on mannitol salt agar. S. aureus small colony variant (SCV) grow as non-
hemolytic, non-pigmented and very small colonies on these media ("' Imm)(8). P. aerllginosa 
SCV are able to grow on 5% Columbia agar and MacConkey agar plates. SCV motphotypes 
of P. aeruginosa vary in colony size between 1-3 mm after 48 hours of incubation (9). 
Enriched chocolate agar with bacitracin is recommended to culture H. influenzae (13). For 
specific isolation of B. cepacia a selective medium containing polymyxin B and bacitracin 
(OFPBL) or a medium containing ticarcillin and polymyxin B (pC agar) is recollll\1ended 
(14,15). 
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For the broad spectrum molecular detection of microorganisms from sputa from CF patients, 
16S rRNA has been used as target molecule. rRNA molecules contain several functionally 
different regions, some of which have conserved sequences and others which are highly 
variable. The 16S rRNA sequence of a species is a stable genotypic feature which may be 
useful for the identification of microbes at the genus or species level. DNA probes based on 
the sequences ofthese unique target regions are useful in identifying bacterial species. Recent 
studies have employed this teclmique to identify H. ilif/lIeIlZae, S. allrells and P. aerugillosa 
as a pathogen in various infections (respectively 16-18, 19-21, 221 23). The molecular 
technique targeted in our study was bacterial genes for the small subunit ribosomal RNA. 
These genes were amplified from DNA extracted from CF sputum samples, cloned and 
characterized by hybridization and DNA sequencing (24). Oligonucleotide hybridization has 
perfonned with probes for the three major CF pathogens (25). 
METHODS OF STRAIN TYPING 
The focus of this part of the introduction is the process of analyzing multiple isolates within 
a given species to detennine whether they represent a single strain or multiple different strains. 
The detailed analysis of multiple isolates can contribute to the development of new insights 
into both the epidemiology and the pathogenesis of infection. The epidemiology of 
colonization of CF patients has been studied extensively. First, phenotyping techniques were 
used but around the beginning of the '90-ies the genotyping techniques were introduced. The 
ability to differentiate strains of P. aerugillosa and S. aureliS from medical and envirorunental 
sources and to track patient-to-patient andlor intrafamilair exchange of strains, depends on the 
use and interpretation of available typing methods. Over the years, several typing methods 
have become accepted as means of strain identification. However, each method has its 
limitations, especially ifthey are used alone, are not carefully standardized, and, if samples are 
not tested repeatedly. 
Only a few pheno- and genotyping teclmiques have been used regularly for typing of 
colonizing microorganism from CF patients, and these have been applied in our studies. The 
phenotyping teclmiques, serotyping and pyocin typing, were used for analyzing of 
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P. ael"llgillosa. For typing of S. allrells we did not use a phenotyping technique because it was 
already detemlinated that molecular methods of typing are superior to phenotyping techniques 
for S. al/reliS (26). For our study of H. iJif!lIellzae we used major membrane protein profile 
(MOMP) as phenotyping technique. 
CRITERIA FOR EVALUATING TYPING SYSTEMS 
The results of an individual typing teclmique must be considered in relation to the available 
epidemiological data or to the results of other techniques. Several criteria are useful in 
evaluating typing teclmiques: typeability, reproducibility, discriminatory power, ease of 
interpretation and feasibility (26). Typeability refers to the ability to obtain a result for each 
analyzed isolate; nontypeable isolates are those that give either no results or uninterpretable 
results. Reproducibility refers to the abilityofa typing teclmique to yield the same result when 
the isolate is tested repeatedly or in different institutions. Discriminatory power refers to the 
ability to differentiate among unrelated isolates. Ideally, each unrelated isolate is detected as 
unique. The ease of interpretation for phenotyping techniques is less complicated then for 
genotyping techniques. The interpretation of data obtained by phenotyping teclmiques is based 
on the presence of absence of metabolic or biologic activities as expressed by the whole 
organisms. The results of genotyping techniques show typically patterns of "bands", each band 
representing a discrete bacterial product or DNA fragment. Such patterns may be extremely 
complex, and difficult to analyze by using logical, objective criteria. A typing technique is 
feasible when it is inexpensive and technically accessible, produces rapidly available results, 
requires neither special expertise, expensive equipment, nor restricted reagents and is useful 
for a broad range of microorganisms. 
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PHENOTYPING TECHNIQUES 
1. Serotyping 
Strain differentiation for P. ael"llgillosa by serological techniques is based on the diversity in 
a heat-stable, somatic antigen group -the 0 antigens- and is generally considered the most 
stable and easily applied system. In an effort to standardize the serological typing system, an 
International Antigenic Typing Scheme has been proposed, which defined 17 standard 
antigenic strains (27). Commercially prepared antisera from these strains are available. 
However, serotyping is limited by it's relatively poor level of typeability and discriminatory 
power. Because certain serotypes occur with high frequency, the serotype system may not be 
discriminatory if many or even all strains under investigation possess the same 0 antigen. 
2. Pyocin typing 
Pyocins are antibacterial substances (bacteriocins) that are produced by P. ael"llgillosa. P. 
aerugillosa can produce several pyocins and because the production of pyocins varies 
considerably among strains, the pattern ofpyocin production has been successfully employed 
as the basis for a typing scheme. Pyacin production involves measuring a test organism's 
sensitivity to a set of standard pyocins. Standard pyocin indicator strains and methodology are 
available (28). One of the major difficulties of pyocin typing is the instability of a pyocin 
pattern, since a given pyocin pattern may change with bacterial metabolism. While growth 
conditions ofthe test organism can be standardized in the laboratory, non-bacterial factors such 
as previous antibiotic therapy may alter pyocin productions pattenlS, leading to false 
conclusions regarding the rate of colonization by new strains. Pyocin typing is useful, however, 
when applied in conjunction with serological typing in order to further differentiate organisms 
belonging to the same O-antigen group. 
3. Major Outer Membrane Protein profIling (MOMP) 
For MOMP profiling, cell envelops have to be isolated. The protein composition of these 
envelops can be assessed using denaturing polyacrylamide gelelectrophoresis (SDS-PAGE) 
(29). Subsequent Coommassie Brilliant Blue staining reveals the presence of different variants 
of a limited number ofMOMP's. Using monoclonal antibodies, the individual MOMP's can 
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be further recognized and the differences in molecular weight of similar pro teins from different 
strains can be detemlined (30). The profile, whether or not completed with Western blotting, 
provides a distinct, strains specific characteristic that can be used for (epidemiological) typing 
purposes. 
A phenotypic conversion ofP. ae/'llgillosa is characteristic for the CF lung habitat. Strains vary 
in the composition of peripheral sugar chains of lipopolysaccharide (LPS), their repertoire of 
bacteriophage receptors and the production of pyocins. In conclusion, although phenotyping 
techniques have been of value, such teclmiques have limited typeability and discriminatory 
power. Because phenotypic conversions of P. aerugillosa are characteristic for strains in the 
CF lung habitat, these teclmiques are fhrther hampered by problems in stability and thus 
reproducibility. Therefore phenotypic techniques have largely been replaced by modem 
genotyping for the study of the epidemiology of P. ae/,llgillosa. 
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GENOTYPING TECHNIQUES 
All genotyping techniques are based on the fact that bacterial strains belonging to the same 
species, i.e. isolates of a given species, are likely to more or less differ from each other at the 
level of their DNA sequence. Several commonly used genotypic techniques are: 
1. Random amplification of polymorphic DNA (RAPD) or arbitrarily primed PCR (AP-
PCR). 
This method is based on the differential amplification of DNA fragments using the polymerase 
chain reaction (PCR). The method is unique in that it uses random primers that bind differently 
to the individual genome molecules, which has a clear effect on amplification profiles (31). 
Genomic DNA is amplified under relatively nonstringent annealing conditions and with only 
a single primer of arbitrary sequence to initiate amplification. Following electrophoretic 
separation of amplified fragments, banding pattern comparison is used to classify isolates into 
related and unrelated groups (Figure I). The DNA fmgerprint is characteristic for a strain. 
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Figure I PCR~mediated DNA 
fingerprinting: primcr-
binding site variation. DNAs 
2 and 3 lack a site present in 
DNA 1. This results in 
disappearance of a band in 
the eiectropherogram. In this 
example, multiple primers 
included in a single peR may 
enhance the number of 
polymorphic sites that can be 
detected. 
(Source Van Belkum A, Clio 
Microbiol Rev 1994;7:176. 
With pennission) 
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2. Pulsed-field gel electrophoresis (pFGE) 
This method characterizes native. non-amplified DNA by digesting of genomic DNA by low-
frequency restriction enzymes that cleave the chromosome infrequently, resulting in a 
relatively small number of larger DNA fragments of 10 to 800 kbp in length (32). These 
fragments are then separated by gel electrophoresis. Periodic change in the orientation of the 
electric field during gel electrophoresis allows separation and size detennination of these 
macro restriction fragments. This technique thus relies on the variation in the electrophoretic 
mobilities oflarge restriction fragments of DNA and on the number restriction sites and sizes 
of the fragments. 
3. Variable Number of Tandem Repeats (VNTR) 
Repetitive DNA consists of multi me ric tracts of certain nucleotide motifs (33). These can be 
one nucleotide (homopolymeric) in length up to much longer units. Variable number of tandem 
repeat (VNTR) loci consist of repeat units present in a single locus and showing inter-
individual length variability. With DNA primers bordering constant sequence elements up- or 
down stream of the VNTR, polymorphism in the repeat unit number is documented after DNA 
amplification. Regions bordering the repeats are generally sufficiently well-conserved targets 
to allow for PeR-mediated amplification (Figure 2). Basically, at the genome level the 
variability arises during replication. Because repeat units are identical, neighboring pairs of 
repeat units can fonn erroneous hybrids. These structures cause the DNA polymerase to slip 
(slipped strand mispairing (ssm) see Figure 2), which leads to incorrect replication: repeat units 
are added or deleted. This variability can serve as a molecular clock and, consequently, 
provides DNA type infonnation. 
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Figure 2: Schematic representation of the mechanism of SSM during replication, which results in shortening or 
lengthening ofSSRs. Individual repeat units are identified by. arrows; bulging is the presence ofnon-hase-pair 
base residues interrupting a regular 2-strand DNA helix. Bulging in the nascent strand leads to a larger number 
of tandem repeat units; bulging in the template strand results in a smaller numbers of units. During replication, 
bulges can occur in both strands, and the effect of insertion or deletion can be neutralized by occurrence of the 
adverse event. The number of repeat units can decrease or increase by mliitiple repeals once multiple bulging in 
one strand has occurred. 
(Source Van Belkum A, Microbiol Molecul Bioi Rev 1998:62:277. With penllission). 
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EPIDEMIOLOGY OF RESPIRATORY TRACT INFECTIONS 
The lungs of a CF patient are often colonized with various bacteria and ainvay inflammation 
is already documented at an early age. The main pathogens isolated from the lower respiratory 
tract of these patients are S. allrellS, H. ilif/uellzae and P. aeruginosa. Epidemiological studies 
using pheno- and I or genotyping techniques have not been able to resolve the confusion about 
the routes of transmission, the prevalence of cross-infection, the eventual prevalence of a 
predominant CF 'type', and the number of strains which may colonize an individual patient. 
Several typing techniques have been used to gain insight in the epidemiological questions 
concerning bacterial infections in CF patients. 
StaphylococclIS alll'ellS 
The bronchial colonization ofa CF patient is initiated during infancy, most commonly, by a 
strain of S. ourells (5). However, the epidemiology of S. oureus in CF patients has not been 
extensively studied. It has not been clearly demonstrated whether the same strain or different 
strains are responsible for repeated broncho pulmonary infections or colonization. It is not 
known wether there are cellain types or clones of S. oureus that are preferentially associated 
with cystic fibrosis. 
In 1981, phage typing was perfonned by Shapera et ai, on initial and selected follow-up S. 
aurells isolates from CF patients exposed to repeated courses of antistaphylococcal therapy 
(34). The original S. aureus phage type was supposedly by eradicated from the sputum of 12 
out of29 patients. However, during the follow-up period (3-6 months) S. aureus colonization 
recurred in 10 of these 12 patients. The same phage type was detected again in seven patients 
and a new phage type was found in three patients. Earlier studies had shown no significant 
differences in the distribution of phage types among S. aureus isolates from CF and non-CF 
patients. Thus, no predominant phage type appeared to be associated with the CF population 
(35,36, 37). Albus et al investigated the S. oureus capsular types in CF patients and healthy 
individuals (38). Capsular type 8 strain predominated with a relatively small number of strains 
with capsular type 5 and a similar percentage of strains that were non-typeable. However, also 
these capsular types seemed to be randomly disttibuted between the two groups. 
An epidemiological analysis of S. aureus from 34 CF patients cultured over a period of30 
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months was studied by bacteriophage typing, plasmid profiling, and (in some instances) 
chromosomal restriction fragment pattern analysis (39). Only six out of thirty-four patients 
appeared to be persistently colonized by one type (for up to 10 months) on the basis ofplasmid 
and phage typing. Identical types were observed in 68% of the patients with as many as five 
individuals sharing the same identical strain type. In a French study, S. aureus isolates were 
tested against 14 antibiotics and characterized by esterase electrophoretic typing, capsular 
polysaccharide serotyping and phage typing (40). Again, no S. aureus type was specific to 
cystic fibrosis, the isolates belonging to a wide range of types. Esterase electrophoretic typing 
indicated that S. aureus persisted for long periods in 73% of the patients (followed for at least 
6 months). Only three out of eighty-five CF patients had two persistent strains at the same 
time. 
There are no studies about transmission of S. aureus and the percentage of cystic fibrosis 
patients that cany S. aureus in the anterior nares is also unknown. However, chronic sinusitis 
is a common problem in cystic fibrosis patients. The microorganisms responsible for this 
infection generally are S. aureus or H. influenzae. Umetsu et al suggested that sinus disease 
is associated with pulmonary exacerbation in CF patients (41). 
Phenotyping and genotyping teclmiques have demonstrated that identical S. aureus isolates 
can be found in related and unrelated CF patients(39). This could imply that cross-infection 
exist. However, no evidence has been brought forward that suggest the existence of specific 
CF S. aureus types or clones. 
Haemopltilils illfiue"zae 
H. ilif/uenzae, cultured from respiratory secretions of CF patients, are nearly always non-
encapsulated (42). Non-encapsulated H. ilif/uenzae is a commensal of the upper respiratory 
tract and is found in 50-80% of healthy individuals (43). Occasionally, encapsulated serotype 
b strains may be recovered, most often from CF children less than five years of age. Some 
investigators have found biotype I to predominate in CF patients (42, 44). Biotype 1 has also 
been associated with pulmonary exacerbations in CF patients (45). Moller et al analyzed H. 
ilif/uenzae strains cultured during a 24 months period from CF patients, by MOMP profiling 
and RAPD analysis (46). The results showed that all CF patients were infected with different 
H. ilif/uenzae strains. Furthermore, CF patients were often colonized by multipleH. ilif/uenzae 
21 
INTRODUCTION 
strains, of which some persisted for up to 2 years. The study of Bilton et al showed that large 
numbers of non-typeable H. illflueJlzae were present in sputum from adult CF patients (47). 
Several biotypes and MOMP types were observed, with no apparent association between these 
two phenotypic characteristics. Two studies showed that pairs of siblings shared identical 
genotypes of H. ilif/uellzae which can indicate that cross-infection does occur (44,46). 
Pseudomonas aerllgillosa 
With the advent of effective antistaphylococcal therapy, P. ael'ugiJlosa emerged as the most 
important bacterial pathogen in lung disease of CF patients (48). A unique feature of CF 
patients chronically colonized with P. ae1'llgillosa is the recovery of an unusual morphotype 
from respiratory secretions. The first description of this association was made by Doggett et 
al in the 1960s and since that time, this has been confinned by others repeatedly (49, 50, 51). 
The morpho type was designated mucoid and this was due to the production oflarge amounts 
of polysaccharide that surround the cell. The material has been designated by Pier as "mucoid 
exopolysaccharide (MEP) or alginate capsule" (52). A major factor in epidemiological studies 
of mucoid isolates has been the availability and development of reliable typing methods. In 
particular teclmiques that cope with the viscous nature of the bacterial alginate and loss of 0-
antigenic components of bacterial lipopolysaccharide (LPS) (52). According to the 
International Antigenic Typing System, which is based on the a-polysaccharide component 
of lipopolysaccharide, mucoid strains are usually polyagglutinable (53). The 
polyagglutinability is probably due to a lack of polysaccharide side chains in these 
lipopolysaccharides (54). The role of phenotypic characteristics for studying the epidemiology 
of P. ae1'llgiJlosa in colonized CF patients is controversial. Until the late eighties serotype, 
phage type, pyocin type and antibiogram were used as epidemiological markers. In 1987, Ogle 
et al developed a molecular probe, cloned from the region for exotoxin A gene (55). The probe 
appeared to be useful to study the epidemiology of P. ael'ugillosa. The results suggested that 
genotypes persist during and after antimicrobial therapy and that more than one genotype can 
be present in the lungs at the same time. In addition, genotypes can also change over time (56). 
Speert et al used a pilin probe to compare the restriction fragment length polymorphism 
patterns of sequential isolates collected over a period of seven years from 23 patients (average 
4 specimens per patient) and observed that most CF patients are colonized for prolonged period 
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with a single RFLP type (57). The international P. aerugil/osa typing study group compared 
different phenotyping techniques with a genotyping technique for P. aerugil/osa strains from 
CF patients (58). The RFLP typing methods seemed to have the best discriminatory power. 
Since 1990s many studies have used genome macrorestriction analysis to determine diversity 
and/or variability of P. aerugil/osa isolates ofCF patients (59). The results of macro restriction 
of P. aerugil/osa DNA and genome fingerprinting by PFGE also showed the persistence of 
single clones in some CF patients (60, 61, 62, 63). Romling et al observed predominant clones 
in each of four different clinics (60). Recently, genotyping ofP. aerugil/osa from CF patients 
by arbitrary-primed or random amplified polymorphic DNA PCR has been reported (64, 65, 
66). Overall, most CF patients become chronically colonized with a single genotype of P. 
aerugil/osa that remains throughout the patient's lifetime (66). However, transient or 
pennanent co-colonization with more than one genotype occurs in 20-30% of all patients. 
Direct genotyping of P. aerugil/osa in sputum of chronically colonized CF patients revealed 
that the airways are colonized with a homogeneous population of the same P. aerugil/osa 
genotype (67). 
The original source of P. aerugillosa responsible for lung infections in CF is still unknown. 
Possible routes of transmission are endogenous carriage, environmental acquisition, direct 
patient to patient contact (hospital or elsewhere) or through contamination ofthe environment 
by CF sources. Speert et al determined that P. aerugil/osa isolates ofthe gastrointestinal tract 
are not identical to isolates of the lungs (68). Laraya-Cuasay investigated the carrier rates of 
CF patients and non-CF family members and found no increased carriers (69). None of the CF 
patients carriedP. aerugil/osa in their nares. Only a few comparative studies of strains isolated 
from patients and enviromnent were done. In 1983 Zimakoff et al tried to identify the possible 
reservoirs and routes of cross-infection by taking samples from patients, staff and the 
enviromnent in a cystic fibrosis centre (70). The study showed that the large reservoir 
presented by CF patients gives rise to contamination of the environment resulting in cross-
infection of other patients. After changing the isolation and hygienic precaution procedures 
they found no P. aerugil/osa types shared between enviromnent and CF patients (71). The 
results of the study of BoJlhammer et al showed that rooms reserved for colonized patients 
were morc frequently contaminated with P. aeruginosa but no direct exchange between 
patients' strains and environmental strains was detected (72). However, the frequency of cross-
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infection through direct patient to patient contact remains a controversial issue. Although, 
many studies have tried to establish the incidence of cross-infection (see Table I). 
Burkltolderia cepacia 
B. cepacia was first described in 1950 by Burkholder as a bacterium responsible for rot of 
onions (86). In addition, it is conunonly found in soil and water. B. cepacia has become an 
important pathogen for CF patients. Acquisition of B. cepacia in the lungs ofCF patients may 
be associated with a rapid decline in puhnonary function with increased morbidity and 
mortality (87). Many epidemiological studies of B. cepacia, using different pheno- and 
genotyping techniques, have reported an identical genotype among CF patients in the same CF 
centre (88, 89, 90). This suggests that some individuals acquire the organism from other 
patients, either directly or via the immediately shared environment. Long-tenn colonization 
with a single genotype was also documented (91, 92). For this thesis we have not studied 
B. cepacia. 
24 
Table 1 A review of literature concerning the occurrence of P. aeruginosa cross-infection among cystic fibrosis patients 
First Author Year CF Center Summer camp Cross-infection Typing technique refnumber 
H0iby 1980 + yes se,ph 73 
Kelly 1982 + highly unusual se, py 74 
Speert 1982 + low se 75 
Zirnakoff 1983 + patient~-~environment ph,se 70 
Thomassen 1985 + little evidence se, asp, ss 76 
Pedersen 1986 + patient-to-patient se, ph 77 
Speert 1987 + minimal se 78 
Grothues 1988 little evidence se, ph, py, FIGE 59 
Tiimmler 1991 + yes se, ph, py, PFGE 79 
Govan 1992 + relatively rare ? 80 
Boukadida 1993 + no evidence FlGE 81 
Romling 1994 + yes se, ph, py, PFGE 66 
Hoogkamp-Korstanje 1994 + relatively rare se, ph, py, RAPD 82 
Cheng 1996 + yes PFGE, fgp 83 
Farrell 1997 + yes ? 84 
Adams 1998 + + yes AP-PCR, PFGE 85 
Note: phenotyping techniques: se:serotyping, ph: phagetyping, py: pyocin typing, asp: antibiotic susceptibility patterns, ss: serum sentivity assay genotyping 
techniques: FIGE: field inversion gel electrophoresis, PFGE: pulsed-field gel electrophoresis, RAPD: random amplification of polymorphic DNA, fgp: 
flagellin gene polymorphisms, AP-PCR: arbitrarily primed polymorphic chain reaction 
?: typing method not specified 
N 
V> 
INTRODUCTION 
AIM OF THE STUDIES PRESENTED IN TIDS THESIS 
Epidemiological studies using phenotyping methods have so far failed to resolve the confusion 
about the prevalence of cross-infection, and the number of strains which may colonize an 
individual patient simultaneously and in the course oftheir disease. Isolates of P. aerugillosa 
with differing morphological characteristics and antibiograms have been cultured from single 
sputum samples of individual patients. This observation together with reported difficulties in 
typing of bacterial isolates of CF patients has presented detailed studies into the number of 
types of a given pathogen species which might colonize an individual CF patient. It is known 
that microorganisms may be replaced by another species of microorganism or other types 
belonging to the same microorganism. To gain further insight into these problems, 
epidemiological investigations based on molecular typiug methods are needed. 
Therefore, the specific aims of our studies were: 
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The evaluation of various typing methods as microbiological tools to help elucidate the 
epidemiology of respiratory tract infections in patients with cystic fibrosis. 
To study the long-tenn colonization of microorganisms ofthe respiratory tract of individual 
cystic fibrosis patients and their environment. 
To explore molecular methods in the detection and identification of microorganisms in 
sputum from cystic fibrosis patients. 
CHAPTER 1 
OUTLINE OF TIDS THESIS 
In chapter 2 the discriminatory power of two genotypic and two phenotypic techniques for P. 
aerugillosa is evaluated by analysis of P. aerugillosa sputum isolates serially obtained over 
long intervals from 29 independent CF patients. 
In chapter 3 pulsed-field gel electrophoresis is compared with arbitrary primed polymerase 
chain reaction for typing P. aeruginosa isolates. 
In chapter 4 P. aerugillosa isolates recovered from sputum specimens of six pairs of CF 
siblings during a longitudinal study were analyzed to study the epidemiology, especially the 
occurrence of cross-infection, by using arbitrary primed polymerase chain reaction as the 
typing method. 
In chapter 5 S. allrells isolates from related and unrelated CF patients were genotypically 
typed by using arbitrary primed polymerase chain reaction for studying the epidemiology of 
S. aureus infection and the occurrence of cross-infection. 
In chapter 6 the existence of variation in tandem repeat loci in H. injlllenzae isolates during 
persistent colonization of CF patients is described as is its possible relation to modulation of 
bactedal virulence. 
In chapter 7 the comparison of microbiological cultivation and molecular methods for 
detection of S. at/reus, H. injluellzae and P. aerugillosa in CF sputum samples is described. 
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PSEUDOMONAS AERUGINOSA: PHENOTYPING VERSUS GENOTypING 
ABSTRACT 
Objectives: To assess the discriminatory power of two genotypic and two phenotypic 
techniques by analysis of Pseudomonas ael'llginosa sputum isolates obtained with long-term 
intervals from 29 independent cystic fibrosis (CF) patients. 
Methods: Fifty eight strains of P. ael'llginosa were subjected to serotyping and pyocin 
production was assessed. Arbitrary primed polymerase chain reaction (AP-PCR) and pulsed 
field gel electrophoresis (pFGE) were applied in order to detect genetic polymorphisms. 
Results: From the results of different typing techniques, it appeared that the numbers of 
separate types varied between II and 43, and the percentage of identical P. ael'llgillosa pairs 
from individual patients varied between 51 % and 72%, depending on the test system used. AP-
PCR and PFGE displayed enhanced resolution when compared to serotyping and pyocin 
typing; both DNA typing techniques generated concordant results, although differences in 
resolution are apparent. This results in 15% discordance, which may be the result of differences 
in the definitions of(sub)clonal relatedness as applied for AP-PCR and PFGE, respectively. 
Conclusions: Molecular typing teclmiques are superior to phenotyping where P. aerugillosa 
is concerned. AP-PCR is a fast and useful teclmique for determining c10nality among P. 
ael'llgillosa strains from chronically colonized CF patients. It is clear, however, that the 
interpretation of data and comparative analysis of PFGE and AP-PCR results necessitates 
additional (international) standardization and the development of practical guidelines. 
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INTRODUCTION 
The lungs of patients with cystic fibrosis (CF) provide an ecologic niche which supports the 
growth of several species of potentially pathogenic microorganisms. Haelllophillis illjllleJlZae. 
StaphylococclIs aureus and Pseudomonas aerugillosa are encountered frequently in sputum 
surveillance cultures of CF patients. P. aerllgillosa causes significant morbidity and is 
associated with a reduction in the life-expectancy of individuals suffering from CF (1). For this 
reason it is important to gain insight in the modes of acquisition and transmission of 
Pseudomonas among patients. 
Over time, the lungs of CF patients are consecutively colonized by different populations 
of microorganisms, indicating complex ecologic dynamics. In order to determine the 
mechanism enabling bacteria to colonize CF lungs for extended periods of time, it is necessary 
to perfonn longitudinal studies forunraveting bacterial population genetics. For detelmination 
of the putative clonal origin of the various strains inhabiting the CF patients' lung, several 
phenotypic and genotypic strategies have been employed. These vary from relatively simple 
biological assays to complex molecular genetic approaches. Several ofthese typing procedures 
have been compared in large, sometimes multi center, typing studies of P. aeruginosa and 
Blirkhoideria cepacia from CF patients (2-5). However, since these studies were perfonned, 
several new methods have been brought forward, among which are the arbitrary primed 
polymerase chain reaction (AP-PCR) (6,7) and pulsed field gel electrophoresis of DNA 
macrorestriction fragments (PFGE) (8). 
The aim ofthe present study was to compare the widely used phenotyping procedures with 
the more recent genotypic strategies. For this reason a collection of 58 P. aerugillosa strains 
from 29 cystic fibrosis patients was analyzed by serotyping, pyocin typing, AP-PCR and 
PFGE. 
MATERIALS AND METHODS 
All 29 cystic fibrosis patients were recmited in the University Hospital Rotterdam (the 
Netherlands). The mean age ofthe patients was 18,6 years (range: 6 to 28) and they had been 
37 
PSEUDOMONAS AERUGINOSA: PHENOTYPfNG VERSUS GENOTYPfNG 
admitted to the hospital on up to 10 occasions (median 6) during the study period. Per CF 
patient, two strains of P. aerugillosa were isolated from two sputum samples. The sample was 
collected during a period of hospitalization or at the time of an out-patient visit. The interval 
between first and second sample was at least 29 months. Strains were isolated by standard 
microbiological procedures and the isolates were stored at -70'C. If two or more 
morphologically different strains were observed upon cultivation, only one was arbitrarily 
selected and used to assess the discriminative power of the four different typing techniques. 
The 29 pairs of strains were characterized by serotyping and active pyocin typing as described 
by Hon-evorts (9). The O-antisera that were used were obtained from Diagnostics Pasteur 
(Marne-la-Coquette, France). AP-PCR was perfonned as described before (10, II). Since the 
efficacy of random primers in an AP-PCR test cannot be predicted accurately, the following 
primer species were first evaluated using a pilot group of 10 P. ael'ugillosa strains: 1283 
(GCGATCCCCA), 1281 (AACGCGCAAC), 1254 (CCGCAGCCAA), 1247 (AAG-
AGCCGT), 1026 (GTGGATGCGA), 14307 (GGTTGGGTGAGAATTGCACG), 40730 
(GGCCATAGAGTCTTGCAGACAAACTGC), 1290 (TACA TTCGAGGACCCCTAAGTG), 
ERIC I (CACTTAGGGGTCCTCGAATGTA) and ERIC 2 (AAGTAAGTGACTGG-
GGTGAGCG ). The latter two primers were also applied in combination in a single PCR test. 
Banding patterns were inspected visually, and all different fingerprints, even when only a 
single different band was observed, were assigned a number. Macrorestriction analysis of DNA 
by PFGE was done according to the methods described by Kaufmann and Pitt (12). Briefly, 
bacteria were immobilized in agarose blocks and the DNA was extracted and digested with 
XbaI (Boehringer-Mannlwim, Genuany). The fragments were separated by PFGE ina CHEF-
DR II apparatus (BioRad, Veenendaal, the Netherlands) for 36 h with initial and final pulses 
of 5 and 25 s, respectively. The gel was stained with ethidium bromide and photographed 
under UV transillumination. Profiles were compared visually. Identical profiles were 
considered major PFGE-types and designated by letters. The subclonal variants, i.e. tracks of 
the same general profile but differing in positions of one up to five bands of the major PFGE-
types, are indicated by subnumbers. 
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RESULTS 
First, we assessed the discriminatory power of 10 different AP-PCR primers by studying a 
limited set of five pairs of P. ael'/lgilloso. It appeared that primer 1290 provided maximum 
discrimination in a single assay (see Figure I for some examples). Subsequently, a1158 strains 
were typed with this particular primer, 1290. All results obtained are summarized in Table I. 
Depending on the typing strategy, a certain percentage of strains remained non-typeable. The 
typeability varies from 100%, 93%, 91 % to 66% for AP-PCR, PFGE, serotyping and pyocin 
typing, respectively. Four strains were non-typeable by PFGE; this was probably related to a 
high intrace11ularcontent of endonucleases (see also reference 13). Apparently, AP-PCR is less 
sensitive to this type of artifact. The numbers of types that could be identified among the 58 
strains by the different techniques were 43 (AP-PCR), 30 (pFGE), 11 (serology) and 14 
(pyocin). Based on these data, AP-PCR and PFGE seem to be superior for typing of P. 
aeruginosa isolates. 
The different typing techniques (AP-PCR, PFGE, serology and pyocin typing, respectively) 
scored 51 %, 58%, 72% and 66% of the paired isolates as identical. This is in agreement with 
the decrease in resolution as described above. When the result of the two genotypic analyzes 
were compared, concordant conclusions with respect to strain identity in pairs from a single 
CF patient were obtained in 85% ofthe cases. For serology and pyocin typing, the percentage 
of concordance was only 58%. When genotypic and phenotypic results were compared, even 
lower percentages of homology were found. The second strain from patients 3, 6, 8 and 19 and 
both strains from patients 15 and 28 were identical with PFGE (e type), but were not clustered 
on the basis of AP-PCR, serotyping and pyocin typing. Strain I from patient 8 and both strains 
from patient 16 were identical with PFGE and different with AP-PCR, serotyping and pyocin 
typing. Four pairs had a different DNA pattern with AP-PCR and had a subclonal (nearly 
identical) variant with PFGE. 
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Table 1 Colonization period and typing results of pairs of Pseudomonas aernginosa strains isolated from 29 chronically colonized CF patients. 
Date isolation Serotype Pyoein AP-PCR PFGE 
Gender Strain Strain Strain Strain Strain Strain Strain Strain Strain Strain 
No (M/F) Year of 2 2 2 2 2 
birth 
F 1972 5/84 9/90 13 13 35b 35b e el 
2 F 1973 9/85 10/90 6 6 45e 45e 2 2 d d 
3 F 1970 10/85 7/91 14 14 84b 84b 3 3 NT e 
4 M 1964 5/84 3/91 13 16 NT NT 4 5 k 
5 F 1966 9/83 5/91 3 3 74e 74e 6 6 a al 
6 F 1972 11186 8/91 8 8 74b 74b 7 8 f e 
7 M 1973 3/84 1191 6 6 41d NT 9 10 NT 
8 F 1970 11184 7/91 NT NT NT NT II 12 n e 
9 M 1972 12187 4/90 3 3 85e 85e 13 14 g h 
10 F 1978 9/83 4/90 6 5 85e 85e 15 16 m 
11 F 1970 9/83 9/90 3 3 46e 46e 17 17 b b 
12 M 1963 9/83 7/91 13 13 45e 45e 18 19 p p2 
13 M 1974 3/82 6/90 3/13 3/13 45e 45e 20 20 q q 
14 M 1974 11183 4/90 16 16 45e 45e 21 21 r rl 
15 F 1965 2184 7/91 15 15 74e 74e 22 22 e el 
16 M 1969 12/85 7/91 1/3 113 78d 78d 23 24 n nl 
Date isolation Serotype Pyocin AP-PCR PFGE 
Gender Strain Strain Strain Strain Strain Strain Strain Strain Strain Strain 
No (MIF) Year of 2 2 2 2 2 
birth 
17 F 1985 2/86 8/90 6 6 84c 84e 25 25 u u 
18 F 1973 8/85 1191 6 6 54e 54e 26 27 v vI 
19 F 1966 10/84 4191 6 6 85e 85e 28 29 w e 
20 F 1971 4/84 5/90 13 13 82d 85d 30 31 Y z 
21 F 1964 12181 7/91 11 11 lId NT 32 33 0 
22 F 1967 9/85 7/91 113 113 NT NT 34 35 x xl 
23 M 1978 6/85 7/90 3 3 NT NT 36 36 D D 
24 M 1985 1186 1191 NT NT 37 37 E E 
25 M 1978 6/85 1191 1/3 1/10 NT NT 38 38 F F 
26 F 1984 3/86 7/91 116 NT NT 39 39 G Gl 
27 F 1968 10/85 4191 NT NT 85e 85e 40 40 NT NT 
28 F 1964 4/85 1191 3 NT 74e 74e 41 41 e e 
29 F 1969 1184 7/91 6 3 66e NT 42 43 K L 
Note: All typing results are given in separate colunms, each column displaying data for both strains (numbered 1 and 2) from all individual patients. Isolation dates are given 
in month/year. Sero-, pyocin-, PCR- and PFGE-types are explained in the Material and Methods section. NT: non typeable . 
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Figure 1: DNA of fingerprints obtained after AP-PCR with primer 1290. Strain designation are indicated above 
the lanes and are identical to thosedescribcd in table I. Genotypically similar isolates were obtained from patient 
24,25,26,27,28. The strains from patient 8 and 10 show different AP-PCR fingerprints, which in these cases 
is in agreement with PFGE data (see table I). For the strains from patient 27 useful AP-PCR fingerprints are 
gcnerated, despite the fact that PFGE proved unsuccessful. 
M, molecular mass marker. 
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DISCUSSION 
In previous evaluations oftyping schemes for Pseudomonas spp. it has been demonstrated that 
the single genetic approach that was validated, on these occasions the analysis of restriction 
fragment length polymorphism (RFLP), displayed a relatively high degree of resolution and 
reproducibility (3, 8, 13). In the present study we demonstrate the lower resolution of 
phenotypic procedures when compared to DNA typing. This is in agreement with the results 
of a previous study, where itwas demonstrated that analysis of a hybridization-mediated toxA 
RFLP detection was superior to phenotyping. The phenotypic procedures displayed lower 
typeability and discriminatory power. Another problem with phenotyping methods is the 
spontaneous conversion of P. aerllginosa, which can invalidate reproducibility (13). PFGE 
and AP-PCR generally show concordant data, thereby strengthening the clinical conclusions 
that can be drawn from the experimental results. It has to be emphasized, however, that AP-
PCR resolves the two isolates offour patients (12, 16, 18 and 22; see Table I), whereas PFGE 
considers these strains to be identical. This is not due to the technical inadequacy of AP-PCR, 
since norun-to-nm variability was observed and typing of numerous colonies ofa single strain 
always generated sets of identical fingerprints. A major reaSO)l for the discrepancy may be a 
paper one: the lack of standardization of the rules applied for the description of (sub)clonal 
relationships. Additional, multi centered validation studies, as were perfonned for S. at/reus for 
instance (14), are urgently needed in this respect. The conclusion from Mouton et al (15) that 
long-tenn administration of antipseudomonal antibiotics to chronically colonized CF patients 
is associated with the development of resistance was confinned for the pairs that were identical 
with AP-PCR and PFGE (results not shown). 
In recent years a number oflarge-scale typing studies on Burkholderia cepacia, also from 
CF patients, have been published (16-18). These studies demonstrate that person to person 
transmission of B. cepacia does occur, but that the frequency with which this happens depends 
on the clinical setting. When patients are well isolated, e.g. in lung transplantation units, 
patients remain pennanently colonized by a single strain (18). When frequent and unobstructed 
personal contacts are allowed, increased transmission is observed. This implies that the CF 
patient, encountering different environmental strains during day to day life, will continuously 
take up those strains that fit in best in his or her lung ecosystem. Ultimately, colonization will 
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be limited to the occurrence of a single bacterial clone (13). In our patient group, six 
individuals harbored PFGE type e P. aerllgillosa at a certain point in time. The widespread 
occurrence ofthis genospecies is reminiscent ofthe general spread of another genospecies in 
the GerrnanHannover region (13). Further analysis of potential geographic clustering of strains 
requires additional investigations. The results of this study showed that nine patients 
underwent a shift in the colonizing P. aerugillosa strain as measured by AP-PCR. Since the 
primary goal ofthe present study was to position the different typing procedures, it is currently 
not clear whether this is an accurate or biased reflection of the actual clinical situation. The 
strains were arbitrary chosen and more detailed studies are needed. We are currently typing all 
the longitudinal P. aerllgillosa isolates from families of CF patients known in our hospital. 
Data from such studies will shed light on colonization convergence and cross-infection in and 
between the family members. 
Presently, a PFGE defined subclone may differ in the position of up to five bands with the 
clonal type, whereas in case of AP-PCR a single band difference led to the definition of 
another type. These widely differing approaches for clone/subclone description may be an 
explanation for differences encountered between PFGE and AP-PCR data as shown in this 
present study. Current research is focused on detennination of sub clonal variants of AP-PCR 
patterns in comparison with PFGE types and subtypes. The validity of this type of research is 
underscored by a recent publication (19), where AP-PCR is brought forward as an excellent 
first-line typing procedure, especially where large numbers of strains need molecular typing. 
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ABSTRACT 
Eighty-seven strains of Pseudomonas aeruginosa were typed by random amplification of 
polymorphic DNA (RAPD) and pulsed field gel electrophoresis (pFGE) of macrorestriction 
fragments. Strains were clustered on the basis ofinterpretative criteria as presented previously 
for the PFGE analysis. Clusters of strains were also defined based on the basis of 
epidemiological data and subsequently reanalyzed by RAPD. It was found that in an RAPD 
assay employing the enterobacterial repetitive intergenic consensus sequence ERIC2 as a 
primer, single band differences can be ignored: in this case clonaBy, related strains could be 
grouped as effectively and reliably as withPFGE. These data could be corroborated by the use 
of other primer species. However, some primers either showed reduced resolution Of, in 
contrast, identified DNA polymorphisms beyond epidemiologicaBy and PFGE-defined limits. 
Apparently, different primers define different windows of genetic variation. It is suggested that 
criteria for interpretation of the ERIC2 PCR fingerprints can be simple and straightforward: 
when single band differences are ignored, RAPD-deterrnined grouping of P. ael'llgillosa is 
congruent with that obtained by PFGE. Consequently, this implies that RAPD can be used with 
trust as a first screen in epidemiological characterization of P. aerllginosa. The ability to 
measure the rate of molecular evolution of the P. aerllgillosa genome clearly depends on the 
choice of restriction enzyme or primer when RAPD or PFGE, respectively, is applied for the 
detection of DNA polymorphisms. 
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INTRODUCTION 
Molecular typing of microbial pathogens is of pivotal importance in the elucidation of 
transmission routes. By closely monitoring genetic variability, phylogenetic distances can be 
measured, and these data can give insight into the interrelationship of bacterial, protozoan or 
flmgal isolates (17). Detailed genetic analysis at the species level gives insights into the 
variability within a bacterial population and generates evidence on genome plasticity and 
evolution, which in tum leads to bacterial adaptation to various enviromnental conditions. This 
type of information can be used in clinical settings to discriminate ongoing epidemics of 
infectious agent from an incidentally increased infection rate. Various molecular strategies 
have been adapted to an experimental fonnat such that the data obtained can help the clinical 
microbiologist to indicate potential risk factors and to track down sources of epidemic strains 
(16). Besides the technical point of view, several major questions still exist, however. Firstly, 
there is no general agreement on the optimal typing strategy to be used for a given pathogen 
(31, 32). Secondly, although there is a general concordance among typing procedures when 
comparative analyzes are perfonned, sometimes discrepancies are obvious (22). The 
assessment of such discrepant results seems to be possible only when further molecular details 
about the respective organisms are made available. It has been suggested that combining data 
obtained by differing typing procedures will give optimal insight into strain relatedness (32). 
However, only a small number of studies describe in detail the basis of the variability observed 
between different typing techniques. 
The aim of the present study was to detemline to what degree two frequently used genetic 
typing procedures give concordant results, using clinical and environmental strains of Pseu-
domonas aeJ'ugillosa. Since standardization of restriction site variation, as detected by pulsed-
field gel electrophoresis (PFGE) and annealing site variation in random amplification of 
polymorphic DNA (RAPD) has not been discussed before, sets of clonally related and 
unrelated isolates of this opportunistic bacterial pathogen were compared in detail. 
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MATERIAL AND METHODS 
Bacterial strains: Strains were selected on the basis of their PFGE-detennined genotypes, the 
detennination of which has been described in previous publications (24, 25, 27) (see below for 
technical details and Table I for a survey of strain characteristics). Four groups of strains were 
gathered. Firstly, the entire Z group (n=24) belonged to a single clonal type (pFGE C-type). 
PFGE banding patterns differed by up to six new restriction fragments. Strains derived from 
environmental and clinical sources and various subtypes were represented. The G group (n= 16) 
was comprised of clearly differing strains, seven different ATCC strains were included as well. 
PFGE banding patterns displayed gross differences, always exceeding the minimum number 
of six differently oriented DNA restriction fragments. One of the strains in this group was 
identical to a member ofthe Z group (internal control duplicate). In the R group (n=25) several 
small clusters of identical pairs or triplets were mixed. The strains in this group were 
epidemiologically unrelated but showed similar PFGE pattems. Finally, the B group (n=22) 
contained several sets of strains with identical PFGE pattems. 
Table 1 Compilation ofPFGE and RAPD typing data for strains of P. aeruginosa a 
Strain no. PFGE type Source of isolation b Date of isolation RAPDtype 
(mo/yr or yr) (ERIC21I 290) c 
ZI C P8, CF, Hannover 8/86 NA 
Z2 CI P8, CF, Hannover 4/87 NA 
Z4 C3 P8, CF, Hannover 11/89 NA 
Z6 C5 P9, CF, Hannover 11187 NA 
Z7 C6 P9, CF, Hannover 6/88 NA 
Z8 C7 PIO, CF, Hannover 5192 NA 
ZIO C9 P4, CF, Hannover 4/86 NA 
ZII CIO P4, CF, Hannover 4/87 NA 
ZI2 CII P II, CF, Hannover Not known NA 
ZI3 CI2 P II, CF, Hannover 7/84 NA 
ZI4 Cl3 P12, CF, Hmmover 1/85 NA 
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Strain no. PFGEtype Source of isolation b Date of isolation RAPDtype 
(mo/yr or yr) (ERIC2/1290) , 
ZI5 CI4 P12, CF, Hannover 12/85 AIIB 
ZI6 CI5 P12, CF, Hannover 3/87 AlA 
Z17 CI6 P12, CF, Hannover 5/87 AliA 
ZI8 CI7 clinical environment, Hannover 12/89 A2/A 
ZI9 CI8 clinical environment, Hannover 12/89 A2/A 
Z20 CI9 PI, CF, Hannover 2/89 AlA 
Z21 C20 butchery, tapwater, Muelheim 92 AlA 
Z22 C21 river, Muelheim 92 AlA 
Z23 C22 swimming pool, Muelheim 92 AlA 
Z24 C23 ear isolate, Heidelberg 92 AlA 
Z25 C21 river, Muclhcim 92 AlA 
Z26 C P8, CF, Hannover 1/86 AlA 
Z27 CO ATCC 33351, serotype 4 Not known B/C 
GI CP ATCC 14886, soil Nofknown C/D 
G2 CQ ATCC 33348, serotype I Not known DIE 
G3 CR patient, Heidelberg Not known ElF 
G4 CS outer ear infection, DSM 1128 Not known FIG 
G5 C PS, CP, Hannover (=Z26) 1i86 AlA 
G6 AK hum wound, Hannover 1989 G/-
G7 CT ATCC 10145, neotype Not known H1H 
G8 M PIS, CF, Hannover 6/91 III 
G9 BB clinical environment, Hannover 12/89 J/J 
GlO CU ATCC 33818, mushroom Not known K1K 
Gil DM CP, not from Hannover 1984 L/L 
Gl2 PAK reference lab strain, Hannover Not known MIH 
Gl3 PAO reference strain, wound, 1955 N/-
Melboume 
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Strain no. PFOE type Source of isolation b Date of isolation RAPDtype 
(mo/ye or yr) (ERIC2fI290) , 
014 CV ATCC 15691 1950 OIM 
Gl5 CW ATCC 21776, soil, Japan Not known PIN 
016 CX ATCC 33356, serotype 9 Not known Q/-
BI P6, CP, Hannover 1/90 RIO 
B2 P6, CF. Halll10vcr 1/90 RIO 
B3 P6, CF, Hannover 11/90 RIO 
B4 P6, CF, Hannover 3/91 RIO 
B5 P6, CF, Hannover 3/91 RIO 
B6 P6, CF, Hannover 9/91 RIO 
B7 P6, CF, Hannover 9/91 RIO 
B8 C P9, CP, Hannover 4/89 AlP 
B9 C P9, CF, Hannover 7/89 AlQ 
BIO C P9, CF, Hannover 8/90 AI-
BII F P2, CF. Hannover 8/90 S/-
BI2 C P9, CF, Hannover 8/90 AlP 
Bl3 C P9, CF, Hannover 5/91 AlQ 
BI4 G5 P3, CP. Hannover 10/89 TIR 
BI5 G5 P3, CF, Hannover 7/90 TIR 
BI6 05 P3, CF, Hannover 2/91 TIR 
BI9 F P2, CF. Hannover 8/90 SIS 
B20 C P9, CF, Hannover 8/90 AI-
B21 F P2, CF, Hannover 3/91 SIS 
B22 CY brass tube 92 urr 
B23 CY sink, private household 92 urr 
B24 CY sink, private household 92 urr 
RIO M3 clinical environment, Hannover 11/93 V/W 
RI9 M3 clinical environment, Hannover 12/89 Wib 
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Strain no. PFOEtype Source of isolation b Date of isolation RAPDtype 
(mo/yr or yr) (ERIC211290) , 
R24 M5 clinical environment, Hannover 12/89 Wid 
Rll K P II, CF, Hannover 7/85 XIX 
R20 K2 PI I, CF, HalUlover 2/91 XiC 
R3 JIO pond, Muelheim 92 YIP 
R12 Jl P7, CF, Hannover 9/85 YN 
R21 J8 P7. CF, Hannover 7/89 YN 
R25 J7 P12, CF, Hannover 11/89 YN 
R5 A P13, CF, Hannover 12/85 ZIR 
R14 A PI3, CF, Hannover 1/86 Z/Z 
R7 AH P24, CF, Hannover 84 aff 
R16 AH P23, CP, Hannover 84 a!Z 
R22 AH P4, CF, Hannover 84 aIR 
R6 B PIS, CF, Hannover 5/86 b/S 
R15 BI PIS, CF, Hannover 12/86 b/a 
R8 F P2, CF, Hannover 2/85 SIS 
RI7 F2 P2, CF, Hannover 5192 C/d 
R23 F P2, CF, Hannover 5192 SIS 
R13 CZl clinical environment, Muelhcim 92 dI-
R4 CZ sink, private household, 92 dlQ 
Muelheim 
R9 0 P3, CF, Hannover 4/86 TN 
RI8 04 P3, CF, Hannover 5/92 TN 
Subtypes are indicated by affixed Arabic numbers, in case ofPFGE, this may be reminiscent of differences 
in the position of six DNA fragments, while in case of RAPD, the cut off was at more than a single band 
difference. In each of the RAPD tests a single primer was included (either ERIC2 or primer 1290). 
For the source of isolation, patients are identified by a capital P; patients 8, 9, and to are siblings. All strains, 
except for the reference and ATCC strains, derive from Gennany. 
~,not done 
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RAPD analysis: DNA was isolated according to the Celite affinity chromatography protocol 
as described previously (4). The DNA was stored in a buffered solution (10 mM Tris.HCI pH 
8.0, I mM EDTA) at -20'C. RAPD was perfonned on 50 ng of template DNA as presented 
before (23, 33). For each strain of P. aeruginosa, two RAPD assays were perfOlmed. Either 
primer ERIC2 (5'-AAGTAAGTGACTGGGGTGAGCG-3') or primer 1290 (5'-TA-
CATTCGAGGACCCCTAAGTG-3') was employed. Because of the complexity of the R 
group, several strains from within this cluster were also analyzed with a set of other primers. 
These primers were ERIC I (5'-ATGTAAGCTCCTGGGGATTCAC-3'), RAPDI 
(5'-GGTTGGGTGAGAATTGCACG-3'), RAPD7 (5'-GTGGATGCGA-3'), 325 
(5'-TCATGATGCA-3'), 327 (5'-CCTGCTTTGAACACTCTAA TTT -3'), 44 
(5'-CGCTACCAAGCAATCAAGTTGCCC-3') and 70 (5'-CATCGTCGC-
TATCGTCTTCACCAC-3'). Using this same set of primers, some of the strains defined as 
PFGE-identical or -related strains were reexamined as well. After electrophoresis in 1% 
agarose gels, the ethidium bromide stained DNA fragments were photographed with Polaroid 
equipment. Banding patterns were analyzed by two independent researchers and, (sub)types 
were assigned on the basis of single or multiple band differences. 
PFGE analysis: PFGE was perfonned as described previously (9, 26). P. aerugillosa cells 
were embedded in agarose blocks and treated with proteinase K, N-Iauroylsarcosine, and 
EDT A. Before electrophoresis, the DNA was digested with the restriction enzyme SpeI (New 
England Biolabs, UK) and after PFGE banding patterns were visualized by ethidium bromide 
staining and then photographed. Interpretation was also perfonned in accordance with 
previously detennined standards implying that separate types should differ by more than six 
DNA fragments. Each type was coded with a capital leiter, and subtypes were identified by 
numbers. 
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RESULTS 
PFGE data interpretation: The PFGE patterns for all of the strains were detennined in 
previous studies (24, 27) and are summarized in Tables I and 2. Strains from the Z-group were 
considered clonally related (C type, subtypes as indicated in Table I), although the individual 
electropherograms may differ in up to sometimes even six DNA macrorestriction fragments 
(25). The G-, R- and B-group are more heterogeneous, although clusters of related and 
sometimes even identical (by PFGE) strains may be discerned (see for instance strains B I to 
B7 or B22 to B24). 
Table 2 Comparative analysis ofPFGE typed (sub)clonally related strains ofP. aerugillosa by multiple RAPD 
assays 
RAPDtype 
Strain number PFGE type ERlC2 RAPDI 325 44 
RlO M3 V A A A 
RI9 M3 W B B B 
R24 M5 W B B B 
RII K X C C C 
R20 K2 X C C C 
R3 JlO Y D D D 
RI2 JI Y D DI D 
R21 18 Y D DI D 
R25 17 Y D DI D 
R5 A Z E E E 
RI4 A Z E E E 
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RAFDtypc 
Strain number PFGEtype ERIC2 RAPDI 325 44 
R7 AH a F F F 
RI6 AH a F F F 
R22 AH a F F F 
R6 B b G G C 
RI5 BI b G G C 
R8 F S H H G 
RI7 F2 C H 
R23 F S H H G 
B21 F S H H G 
RI3 CZI d J J 
R4 CZ d J 
BI4 G5 T K K K 
R9 G T KI KI L 
RI8 G4 T KI KI L 
Note: Figures in the PPGE types indicate subcJonaJ relatedness: the number of different bands varies between 
1 up to maximally 6. The codes presented for primers ERIe2 and 1290 are in concordance with those given in 
Table 1. For all of the other primers arbitrary codes are given in letters starting with A. 
Integrated analysis of the PFGE and RAPD data: All RAPD derived banding patterns were 
indexed with capital letters. This is exemplified in Figures I and 2, and data are summarized 
in Tables I and 2 in a schematic fonnat as well. 
The number and sizes of DNA fragments generated by RAPD are clearly primer dependent. 
As can be deduced from Figure I, when the ERIC2 primer is employed, between 8 and 15 
DNA fragments ranging from 100 up 2,500 base pairs are synthesized by the Taq polymerase. 
When RAPD I is used, approximately 17 fragments are generated, while for primer 325, 
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between 16 and 19 DNA molecules can be seen after electrophoretic separation (data not 
shown). Sometimes smearing is observed when multiple DNA fragments which differ slightly 
in length are visible. 
The members of the PFGE homogeneous Z-group were shown to generate individually 
similar RAPD banding patterns. From the banding patterns it was concluded that for the entire 
group only five RAPD (sub)types could be observed. When the ERIC2 primer was applied, 
for instance, the two subtypes Al and A2 differed by the presence or absence of only a single 
DNA fragment when compared to the A type. This may imply that single band differences in 
the banding patterns generated in this way do not represent epidemiologically relevant genetic 
differences among related clusters of strains (see also discussion). The only aberrant strain in 
the Z·group is Z27, which was included'as a control sample in this group (pFGE type CO). The 
distribution of fragment sizes shown by this strain was similar to that of genuine clone C 
isolates (24). 
Data obtained for members of the G-group corroborated the PFGE findings. Major 
differences in banding patterns were observed; only in the case of strains Gland G3 were 
somewhat similar patterns documented (still differing at two positions, but no subtypes were 
thus identified) . Both the ERIC2 and the 1290 primers generated concordant results in this 
respect. Note that the RAPD type for strain G5, which is of the PFGE C-type, is identical to 
the RAPD types as established for the majority of the Z strains. 
As can seen in Table I, data obtained for the B group by ERIC2 RAPD show excellent 
agreement with the PFGE codes. All the clusters enclosed are adequately recognized by the 
ERIC2 typing results. In some instances, the banding patterns generated with primer 1290 
identified additional heterogeneity among the related strains (for instance, type f for B8 and 
g for B9). This indicates that this particular primer may give rise to an overestimation of the 
actual number of distinct types that can be distinguished in a given collection of P. aerugillosa 
strains. These RAPD fragments may be reminiscent of DNA loci displaying a high speed of 
alteration due to a high frequency of mutation or rearrangements caused by intra- or inter-strain 
exchange of genetic material. 
The most complex set of data was obtained for the R group of strains. In this group, several 
(sub )clonally related strains are present, as was determined by PFGE. In Table 2, the data 
obtained by RAPD are summarized; strains are ordered with respect to the initially assigned 
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PFGE type. As such, it can be deduced that the ERIC2 RAPD tests are in reasonable agreement 
with the PFGE data: again, the ]290 fingerprints show more variability. For this reason, other 
primer species were evaluated for typing efficacy. These experiments resulted in a number of 
interesting observations. It appeared that application of the primers 70, RAPD7 (which is very 
well suited for typing of staphylococci (32), 327 and ERIC] did not generate interpretable 
results. Either the DNA banding patterns were identical for all strains or no DNA was ampli-
fied whatsoever. Data obtained with the prinlers that could be applied successfully are 
summarized in Table 2 and illustrated in Figure 2. From these data, it can be concluded that 
RAPD analysis generates results that compare very well with those obtained by PFGE. The 
RAPD-based grouping is a clear reflection of the PFGE-related clusters. Dependent on how 
the data are interpreted, it is evident that PFGE subtypes may sometimes be defined as 
different clonal types by RAPD. Strains RIO, R 19 and R24, which are PFGE subtypes M3, M3 
and M5, respectively, are grouped into two RAPD types. The ERIC2, RAPD 1,325 and 44 data 
are precisely concordant; only primer 1290 gives rise to an overestimation of the number of 
types that can be distinguished. The latter primer also shows overdiscrimination with strains 
RII and R20. Also, the latter phenomenon can be observed in some of the other groups 
displayed in Table 2. 
Figure I; Examples ofRAPD generated DNA fingerprints for strains of P. aerugillosa genetically clustered in 
four different groups (Z, G, R and B). The primer used was ERIC2. Strains Zl4 to Z18 arc part of the c10nally 
related C-c1uster as defined by PFGE. Note that only single band differences are observed. The second from the 
left shows strains belonging to different clonal entities (227 to G05): all the banding patterns are clearly different. 
In the third (R21 to R25) and fourth (BOI to B I 0) panels, some of the epidemiologically clustered strains arc on 
display. Note that B08 to BIO are identical to the C-type strains showed in the panel on the left. For a detailed 
description of the data see table I. The arrow on the right indicates a molecular length of 800 basepairs. 
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size marker 
RIO 
Rl9 
R24 
Rll 
R20 
ROJ 
Rl2 
R21 
R25 
R05 
R07 
control 
marker 
Figure 2: Comparative analysis of the R group strains ofP. aeruginosa by using different RAPD primers. Clonal 
relatedness was defined on the basis of PFGE, which is summarized in table 2. Note that the schematic 
interpretation of data as presented in this figure is given in the same table. Lanes labeled size marker contain 1 
kb ladder DNA. The arrow on the left indicates an 800 basepair DNA molecule. In the lane labeled "negative 
control", amplimers derived from mixtures containing no extraneous DNA were analyzed. Patterns displayed in 
the panels, going from top to bottom were generated with the help of primers RAPDl, 325 and BRIe2. Note that 
there is identity among the ERIC2 fingerprints that are shown both in figure I and this figure. 
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DISCUSSION 
Pseudomollas aerugillosa is a common pathogen in cystic fibrosis (CF) patients (2, 6, 13). By 
applying molecular typing procedures, it has been demonstrated that the clinical problems 
caused by P. aeruginosa may result from its capacity to also colonize inanimate surfaces for 
prolonged periods oftime (5, 10). Although the relevance of molecular typing for CF patients 
may not be as obvious as it possibly should be, several reports of studies employing molecular 
typing of P. ae1'llgillosa were recently published. Striking examples were the proof of existing 
cross-contamination among neonates in certain clinical settings (34) and a study showing the 
usefulness of molecular typing in gaining insight in the putative "pseudomonad exchange" 
between CF patients spending time in summer holiday camps (I4). Reservoirs could thus be 
identified, and the nosocomial ecology of the microorganism could in some instances be 
unraveled in great detail. In order to perform such studies, the clinical laboratory should have 
appropriate teclillical means at its disposal. Presently the number of typing systems described 
for P. aerugillosa is large (19-21, 2S, 29), but recently, newly developed procedures such as 
PFGE of DNA macrorestriction fragments (9, 26, 29) and RAPD analysis (3, 7, IS) have been 
used for detailed comparisons among clinical and environmental strains of P. ael'llgillosa. 
However, in only a linlited set of studies were the efficacies ofthe typing strategies compared. 
The most elaborate multi centered comparative typing effort for P. ae1'llgillosa was 
presented three years ago (15). This study, which essentially lacked molecular analyzes, 
suggested that serological typing ofthe lipopolysaccharides in the outer surface ofP. ae1'llgillo-
sa provides an efficient means of bacterial typing, especially because it is simple and efficient. 
CF isolates of P. aerugillosa are not-typeable by this method because of their rough phenotype. 
Due to aberrant phenotypic characteristics, CF strains can be reliably typed only by molecular 
methods. This was recently confmned in a study of the colonization of patients with 
bronchiectasis in which the conventional methods proved ineffective (I2). An even more 
recent study included PFGE typing (I I). The experimental results demonstrated that the 
resolution ofPFGE exceeded that of restriction fragment length polymorphism analysis with 
ribosomal or toxin A DNA probes. Nevertheless, strains of the same type were found in 
hospitals at different geographic locations. Finally, these authors emphasize that typing data 
should be interpreted only in the context of sound epidemiological data because, otherwise, 
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unequivocal conclusions with respect to strain persistence or transmission cannot be drawn. 
There is a recent (and still singular) publication that discusses the relationship between data 
obtained by PFGE and that obtained by RAPD for the same set of strains of P. aerl/gil/osa 
(18). The present data indicate that RAPD should serve as a first screen for P. aerl/gil/osa 
typing because of its simplicity and high speed ofthis teclmique and that the bacterial grouping 
results attained coincides with those ofPFGE analysis. The authors of reference 18 do not fully 
discuss the relationship between the two sets of experimental data; neither do they define strict 
interpretative criteria for the PFGE and RAPD DNA banding patterns. The present 
conununication indicates that if single band differences between RAPD derived fingerprints 
are ignored, there is excellent agreement of the RAPD results with the PFGE-based grouping 
of clonally related P. aerl/gil/osa strains. 
The interpretation of data generated by PFGE was the general subject ofa recent and timely 
discussion (31). In this paper, which tried to define guidelines for the interpretation ofthe DNA 
banding patterns in the absence ofa generally accepted technologically standardized approach, 
it was suggested that a difference in the electropherogram of more than three bands should lead 
to the definition of another, new bacterial clone. Subclones are identified on the basis of 
smaller numbers of differences. Such a rigid definition does not take into account biological 
properties such as different degrees of variability in different species. This type of information 
can be gathered, for example, by studying the results of comparative physical mapping of 
bacterial genomes (8) and should be included in epidemiological evaluations when available. 
In the present paper, we show that these criteria may vary by microorganism and that 
measurement of the speed of genomic evolution heavily depends on primer choice or choice 
of restriction enzyme, respectively, when either RAPD or PFGE is involved. In case of P. 
aerugil/osa, the existence of as many as six differences between the PFGE generated DNA 
banding patterns may not mle out clonal relatedness. This is confirmed by the data obtained 
with RAPD primer ERIC2, even if very stringent interpretation criteria are used (only single 
band differences are ignored). Detailed studies of DNA typing and the standardization thereof 
should involve,in case of the interpretative analysis ofRAPD and PFGE, multiple restriction 
enzymes for PFGE and multiple primers for RAPD. These should be optimized for all of the 
medically important microorganisms. This would allow the following typing scheme: by 
screening with RAPD, clonal relatedness can be determined at high speed and relatively low 
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costs. This would enable clinical microbiologists to unravel most ofthe nosocomial epidemics. 
In a second stage, PFGE could be used for confinnation of the RAPD data and for fine-tuning 
the sanitary or clinical measures already taken on the basis of RAPD data. The primary 
critetion for the selection of the restriction enzyme to be used for PFGE pretreatment should 
be the presence of a sufficient number of restriction sites to allow adequate discrimination and 
resolution. 
In conclusion, it can be stated that RAPD provides an excellent first screen for typing of 
P. aerllginosa and this is supported by data obtained by others (l I, IS, 18,31). The interpreta-
tion of data obtained with a single primer, as described in this communication, is 
straightforward: when single band differences are neglected, full concordance with data 
obtained by PFGE may be expected. This makes interpretation of the experimental results 
simple, especially when automated analysis is feasible. The application of RAPD in 
multicentered studies, however, should be subjected to thorough research, since it has been 
demonstrated before that RAPD, although highly reproducible within a single laboratory, may 
generate different experimental outcomes when perfonned in different laboratories (33). 
Although it was recently demonstrated that ribotyping may be as discriminative as PFGE (I), 
in the case of large, (inter)national studies, PFGE may still be the method of choice. On the 
other hand, a simple single primer RAPD test, as described in the present paper, may be 
amenable to multicentered standardization, especially in the context of epidemiological 
investigations by reference labs, and requires a lower level of expenditure than PFGE. 
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ABSTRACT 
The molecular epidemiology of Pseudomollas aerugillosa infection in cystic fibrosis (CF) 
siblings was analyzed by DNA fingerprinting using arbitrary primed polymerase chain reaction 
(AP-PCR). A total of306 strains collected from six pairs ofsihlings over a period of20 - 126 
months (median 64) was studied. Fifty-four different P. ael'ugillosa genotypes were 
recognized. Two out of six pairs of siblings were ultimately colonized by identical strains, and 
it was shown that a single P. ael'ugillosa clone can persist in an individual patient for over ten 
years. No overlap in P. ael'lIgillosa genotypes was encountered between families, whereas in 
all families at least transient cross-colonization with the same genotype was observed. TillS 
finding demonstrates that P. aeruginosa cross-infection or acquisition ofthe same strain from 
an identical enviromnental source exists within the family situation, but does not always result 
in a long-term colonization by identical genotypes in all family members suffering from CF. 
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INTRODUCTION 
Pseudomonas aerugillosa is an organism cOlmnonly occurring in soil, water, plants, animals 
and humans. Nonnally P. aerugillosa is a resident of the intestinal tract in a rather small 
percentage of healthy individuals. It is found sporadically in moist areas of the human skin and 
in the saliva (12). It can multiply in almost any moist environment and has minimal nutritional 
requirements. Moreover, it is tolerant to a wide variety of physical conditions. Consequently, 
the microorganism can be found frequently in the hospital environment and home reservoirs 
such as sinks, floors, baths, soap·dishes and dishcloths (6). Previous environmental sampling 
resulted in frequent isolation of P. aeruginosa and P. pulida / jlllOl'eSCellS from various sites 
in the houses of cystic fibrosis (CF) and non·CF patients (14). Another study documented 
carrier states exclusively in patients with CF and not in healthy members of the same family 
(II). In a regional slndy, Romling et al. (19) identified two separate clones of P. (Jel'llgil/osa 
in CF patients as well as in moist habitats within the hospital environment. Environmental P. 
aeruginosa isolates from moist and aquatic habitats in GennallY apparently contained variants 
ofthe same CF clones. This is in contrast with the results of a slndy in a Danish cystic fibrosis 
centre, where none ofthe patients harboured strains similar to those present in the environment 
(24). From a clinical perspective, colonization with P. (Jerl/gil/osa in CF patients is a common 
problem, but the original source of the organism and the precise mode of transmission 
generally remain unresolved (8,9). Although cross· infection of P. aerl/gil/osa in cystic fibrosis 
siblings is often described (1,3,5,9,18,22, 23), the existence of cross· infection in unrelated CF 
patients remains a point of discussion (8). Several studies showed identity between isolates 
from unrelated patients (3,7,13,15,19,20,22), but others did not (I). The objective of the 
present study was to characterize the genetic polymorphism of multiple P. aerugillosa strains 
isolated from six pairs ofCF siblings followed up for periods of up to 10 years. 
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MATERIALS AND METHODS 
P. aeJ'lIgillosa isolates were collected, from 12 different CF patients belonging to 6 families, 
during hospitalization and/or follow up visits. Isolates were included in the study when lh 2 CF 
patients originated from a single household, Q. both patients were colonized for a minimum 
period of20 months and Q. at least 2 strains were still available for genetic typing. All patients 
were frequently analyzed for microbial colonization of the lungs. Thus, 306 P. aeJ'lIgillosa 
sputum isolates collected from six pairs of CF siblings by the Department of Medical Micro-
biology & Infectious Diseases of the University Hospital Rotterdam (the Netherlands) were 
studied. Strains were isolated by standard microbiological procedures and stored in a viable 
state in glycerol containing media at -70°C. If two or more morphologically different P. 
aerugillosa strains were cultured from a single sputum specimen, all morphotypes were 
included in the study. The 306 strains were characterized by arbitrary primed polymerase chain 
reaction (AP-PCR) with primer 1290 (5'-TACA TTCGAGGACCCCTAAGTG-3') as described 
before (16). Banding pattenlS were interpreted by visual inspection by two independent 
observers and all fingerprints that differed by more than one single band were assigned a letter. 
Differences in ethidium bromide staining intensities were ignored. 
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RESULTS 
Cultivation: The patients' ages and the period of isolation of P. aerugillosa can be deduced 
from Table I for all ofthe CF patients included in the present study. The P. aerllgillosa isolates 
were obtained over a period of20-126 months (median 64). 
Table I Results of cultivation of all sputum specimens from 6 pairs of siblings. 
no. G Year 
2 
3 
4 
5 
of 
birth 
~ 1970 
if 1973 
~ 1982 
if 1980 
~ 1978 
P. aerugillosa sampling 
no. of period 
isolation 
188 1184-0193 
50 0791·0793 
25 0287-1292 
13 0288·0693 
97 0983-0394 
Pseudomonas geno-
for type 
AP-PCR 
66 
9 
2 
4 
33 
A 
B 
C 
D 
E 
H 
G 
E 
C 
A 
A 
B 
C 
B 
A 
o 
p 
Q 
R 
S 
no. of period 
isolates of 
3 
4 
9 
1 
47 
7 
2 
2 
4 
24 
2 
24 
28 
27 
44 
24 
7 
4 
98 
126 
22 
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nn. G Year P. ael'llginosa sampling Pseudomonas geno- no. of period 
of no. of period for type isolates nf 
birth isolation AP-PCR persistence 
months 
6 ~ 1974 226 0883-0893 78 A 15 80 
B 
C 
D 2 2 
E 
G 51 69 
F 
H 
I 
J 
K 
L 
0 
7 a' 1976 10 0987-0590 2 D 2 32 
8 I 1972 94 1181-0990 55 A 47 62 
B I 
C I 
D 2 16 
E 
F 
G 
H 
9 a' 1986 4 1189-0791 4 A 2 10 
B 2 6 
10 a' 1983 38 0589-0793 13 A 9 44 
B 3 29 
C 
II ~ 1975 14 1191-0893 10 A 
B 4 20 
C 4 18 
D I 
12 ~ 1972 77 0890-0793 30 D 15 35 
C 13 25 
B 2 6 
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The other bacterial species isolated from the CF patients were mainly Staphylococcus 
aureus and, incidentally, Haemophilus injluellzae, Acilletobacter anitrallls, Escherichia coli, 
Proteus mirabilis, Streptococcus p"eulnolllae, Stellotrophomonas mallophilia and E1Jlero-
bacter spp. In several instances, strains from the fungal and yeast species Aspergillus 
jilllligatus and Candida alhiealls were isolated. 
Colonization dynamics in the pairs of CF siblings: In the present study, 34 % ofthe spuh,m 
samples (n = 216) yielded 2 or 3 morphologically different P. aerugillosa types. However, in 
63 % ofthese cases the morpho types were genotypical indistinguishable. This can be explained 
by the fact that morphotype variability as for instance caused by lipopolysaccharide changes, 
can be caused by minor genetic events that go undetected by gross genotyping procedures such 
, 
as AP-PCR. It has been demonstrated before that CF populations of P. aerugillosa are 
genetically homogeneous: upon molecular typing of multiple colonies of a single sputum 
culhlfe genetic identity was revealed (21). 
As time progressed, however, most patients harboured several genomic variants. Figure 1 
gives a survey of AP-PCR results obtained for the strains detived from one of them; this 
illustrates the differences in RAPD banding patterns, although persistent colonization by a 
single genotype is obvious as well (see lane 1-7, 9 and 13-16). 
2 3 4 5 6 7 89M 10 11 12 13 14 15 16 17 
Figure I: DNA from P. aerugillosa was amplified with an arbitrary primer 1290. 
Strain designation is indicated above the lanes. The strains are identical to the fIrst 17 strains from patient 6 which 
are chronologically presented in figure 2. (M : molecular mass marker). 
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The number of different genotypes varied per patient (Figure 2). In patient 6 for instance, 
13 different genotypes were identified (A-L and 0, see table I). Altogether, fifty-four different 
genotypes could be recognized by AP-PCR fingerprinting. Figure 2 gives a longitudinal survey 
of P. aerugil/osa genotypes in6 pairs ofCF siblings. In pair I, patient I showed more vadation 
in the beginning of colonization and became long-ternl colonized with genotype E. Patient 2 
shared the same genotype, and two additional genotypes (A and C) were also shared by this 
pair, The precise colonization pattern for patient 3 remains unknown because only two strains 
were available. Patient 4 harboured two genotypes, and the genotype of the last two isolates 
was identical in both patient 3 and 4. Patients 5 and 6 shared 2 genotypes, but became long-
tenn colonized individually with a different strain; 0 and G, respectively, These two strains 
were encountered as potential cross-contaminants in either individual of this pair. Patient 6 
initially acquired a strain (genotype A) that was replaced by another strain (genotype G) 
persisting 71 months. Again, genotype A was found four times, and genotype G was never 
isolated in the other family member. In patient 7, two identical isolates (type D) were cultured 
over a period of20 months. Unfortunately, there were no additional strains available. Genotype 
D was isolated twice from the other sibling who showed more colonization variation in the 
early stages and became long-tenn colonized with genotype A. For patient 9, four isolates were 
available; two genotypes were identified. Both genotypes were identical to the long-tenn 
colonizing strains from patient 10. Patient 10 was colonized with two genotypes of which 
genotype A was frequently isolated. Patient II and 12 shared' genotype B, C and D and were 
colonized with B, C and C, D, respectively. Only patient 8 and, to a lesser extent patient I 
showed more vadation in the number ofbactedal genotypes P. aerugil/osa in the early state 
of colonization. Incidentally, commonP. aerugil/osa genotypes were encountered in all of the 
sibling pairs. This mainly concerned short-tenn (cross-over) canier-ship. Apparently, patients 
exchange bacterial strains or acquire identical types from common environmental source, but 
in general, this does not lead to persistent colonization. Only type E in pair I and type C in pair 
6 are strains that give rise to long tenn colonization in both individuals in a single household 
pair. 
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Figure 2 : Longitudinal survey of Pseudomonas aeruginosa genotypes in 6 pairs of CF siblings. 
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Note: each point represents one month; within each pair each genotype is assigned it's unique letter; if more genotypes of Pseudomonas aeruginosa were isolated 
from one or more sputum samples in one month, it is assigned as different letters, if identical genotypes: A two isolates; A three isolates; A four isolates; C two 
isolates; C three isolates; t> two isolates: t two isolates; E three isolates; 1; four isolates; G two isolates: G three isolates: -0 four isolates; C five isolates: 6 two 
isolates. Note that indices may overlap between pairs but these do not indicate identity (e.g. type A in patient 1 and 2 does not equal type A in patient 5 and 6). 
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DISCUSSION 
CF patients generally acquire P. aerugil/osa strains in their lungs, and during the course ofthe 
colonization the mixture of the strains may vary. Many clinical studies focused on this issue 
for individual patients (1,5,8,20,22). We present a similar study of the dynamics of P. 
ael'uginosa colonization in the CF lung from a family perspective: our analysis aimed at the 
elucidation of long-tenn spread of P. aer/lgil/osa strains within the family situation. For 
molecular typing of the strains we used RAPD analysis for several reasons. Firstly, a major 
problem of phenotyping techniques is the spontaneous conversion ofthe phenotypic markers, 
whereas a lower rate of type ability of P. aeruginosa occurs. Secondly, in previous studies, AP-
PCR andPFGE (pulsed-field gel electrophoresis) displayed superior resolution when compared 
to sero- and pyocin-typing whereas the perfonnances ofPFGE and AP-PCR were comparable 
(10,16). Thus, it is likely that the presence of genetic variation in strains from the CF patients 
can be detected accurately and reliably by a single AP-PCR assay (17). 
In most patients a predominant genotype became persistent. These results are in agreement 
with those of other investigators (2,20). Gnly in patient 2, 3, 8 and II the initial genotype was 
never found again. In six patients who were long-tenn colonized with one genotype of P. 
aeJ'lIgillosa, only shol1-time colonization with other strains was observed. Three patients (10, 
II and 12) were long-tenn colonized with two genotypes. Interestingly, identity in genotypes 
was only established when strains from family members were studied. Between families, no 
overlap in colonizing strains was encountered. These results show that most CF patients ulti-
mately become colonized with a strain which obviously fits best into the micro-environment 
oftheir lungs. Although precise records of antibiotic treatment were not available for all ofthe 
patients, the genotypic data reveal that antibiotic therapy (which is administered velY 
frequently in these patients) does not induce complete bacterial sterilization of the lungs nor 
does it enable a new P. ael'llgil/osa genotype to take over easily. 
H0iby (4) defined colonization to be cbronic when cultures of sputum samples yielded P. 
ael'lIgillosa for six consecutive months andlorwhen two or more precipitins against P. aerugi-
I/osa were present in the semlll. This definition cannot be used for the patients in the current 
study, since none of them was sampled for six consecutive months after the start of P. ael'u-
gil/ostl colonization. Stm1 of chronic colonization according to the criteria postulated by Reiby 
remains therefore unknown in our patients. However, our study shows that chronicity of 
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infection should be based upon detailed genetic analyzes of the P. aerugillosa isolates. 
Frequent (dis)appearance of strains seems to be observed (Figure 2). This can be explained by 
assuming mixed colonization by genotypes that temporarily differ in relative abundancy. 
During exacerbation periods, a given type may outgrow (but apparently not replace) another 
type. This of course causes a selection of the predominant type at the cultivation stage. 
Colonization and infection of CF lungs with P. aerugillosa are highly dynamic processes. 
In our study, four pairs of siblings acquired a genotypical different long-term colonizing 
strain. This is in contrast with previous studies (5,9). The results of our study mainly support 
short-tenn cross-contamination between most related patients. If environmental sources or 
cross-infection were the most important origin of infection in the family situation, we would 
have expected to find a higher colonization rate with identical strains in our pairs of siblings. 
Probably the clinical state of the respiratory tract and the appropriate strain fitting best in the 
CF lung's envITomnent are more significant factors for establishing long-tenn colonization. 
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ABSTRACT 
Background: Cystic fibrosis (CF) patients can become persistently colonized with 
Staphylococcus aureus. This is initiated at an early age and may continue until or sometimes 
even during adolescence. Little is known about the epidemiology and cross-infectivity of S. 
aureus in CF patients, whether via the environmental or perSoll-to-person. 
Methods: S. aureus strains (n=189), isolated from six unrelated CF patients and six pairs of 
CF siblings were genetically typed by arbitrary primed polymerase chain reaction (AP-PCR) 
assays. 
Results: TillS longitudinal study revealed 35 different genotypes among the 189 strains, the 
median number of types in a patient was three (range I - 6). One common S. allrells genotype 
was found in six patients and involved twenty percent of all strains analyzed. Ultimately, in 
most of the patients long-tenn colonization with a single genotype was observed. In several, 
but certainly not all, pairs the siblings became persistently colonized with isolates that could 
not be discriminated by the typing method used; different S. alirellS genotypes were isolated 
on an incidental but relatively frequent basis. Only one pair of siblings never shared identical 
strains at any moment of time during the screening period. 
Conclusions: In five of six cases, identical isolates were shared by CF siblings at a certain 
time. This suggests intra-familiar transmission or the presence of a common enviromnental 
source. The fact that in most of the CF sibling pairs different genotypes of S. allrells caused 
the ultimate long-tenn colonization indicates that, despite regular cross-colonization, patient 
characteristics select the S. allrells strain best adapted to the affected lung. Some genotypes 
may be particulary prevalent in the CF patient population, but additional studies are needed 
to confinn this. 
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INTRODUCTION 
Cystic fibrosis (CF) is caused by mutations in the transmembrane conductance regulator gene 
and is attended by chronic infections of the airways (1,2). The lower respiratory microflora in 
young CF patients generally includes Staphylococclis allrells and Haemophillis ilif!lIenzae (I), 
while Pseudomollas ael'ugillosa is the most common pathogen encountered at a higher age. 
This shift in species prevalence is largely unexplained but it has been documented that P. 
aerugillosa is capable of producing substances that may inhibit the growth of, for instance, S. 
alirellS (3). The pathogenicity of S. alirellS in CF patients has been addressed previously from 
various experimental perspectives. It has been proposed, for instance, that the bacteria from 
CF patients may siroply attach more finnly to CF mucosal cells (4). Strongly adherent S. 
allrells strains could be selected on the basis of their affInity for CF epithelia, or on the other 
hand, the local conditions in the CF lung may induce an adherent phenotype. Several S. aurells 
typing studies, however, failed to demonstrate the increased prevalence of a 'CF-associated' 
types (4,5,6). Capsular types appeared to be randomly distributed and no increased anti-capsule 
antibody levels were encountered among CF patients (5). Esterase electrophoresis, capsular 
polysaccharide serology, phage typing and antibiogram detennination on several hundreds of 
French CF-derived S. allreliS isolates also failed to identifY a particular CF- type strain (6). 
The long-tenn colonization of S. al/l"eliS in cystic fibrosis patients has not been studied in 
great detail yet. The purpose of the present study was to assess the diversity and variability of 
S. allrells isolates in CF patients and to detennine whether transmission in the family situation 
is a frequent event. The epidemiology of S. allreliS in CF patients was studied with the 
application of arbitrary primed polymerase chain reaction AP-PCR (7). 
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MATERIALS AND METHODS 
CF patients and microbiological surveillance: Sputum samples from CF patients were 
analyzed by standard microbiological techniques, Portions of sputum were washed twice in 
physiologic salt solutions and inoculated on blood agar or chocolate agar, Longitudinal S, 
allrells isolated from two groups of CF patients were evaluated, The groups were defined as 
follows: group 1, CF patients who were living in a geographically different area and did not 
share the same room or ward during their hospitalization; and group 2, pairs of siblings from 
a single households, The selection criteria for group I, comprising six unrelated selection 
criteria for group I, comprising six unrelated, clinically confmned CF patients, were: persistent 
S. Gureus colonization for more than 6 years, with at least 5 isolates still available for genetic 
analysis, For group 2, comprising six pairs of CF siblings, the criteria were that both CF 
patients had been colonized withS, allreus for at least 5 months and had more than two isolates 
available in the archival S, alireliS collection, At the same time, the culture results of all sputum 
samples taken from these patients were evaluated, 
Bacteria: A total of 189 isolates of S, alireliS were collected from sputum samples derived 
from CF patients attending the Department ofPuinlOnary Disease which were analyzed by the 
LaboratOlY for Medical Microbiology (University Hospital Rotterdam, the Netherlands), The 
S, allrells isolates were stored in soy tryptone broth supplemented with 15% (vol/vol) glycerol 
at -70°C, To detennine the genetic homogeneity of the S. alireliS populations inhabiting the 
lungs of a given CF patient, 10 colonies of S. aurells isolates encountered in a primary culture 
of five different sputa were stored as well, 
Genotyping: AP-PCR was perfonned according to the methods as described by Kluytmans 
et al.(8) and van Belkum et al (9,10). For DNA isolation, bacteria were resuspended in 150 III 
ofTEG buffer (25 mM Tris, 10 mM EDTA, 50 mM Glucose, pH 8,0) and 75 III lysostaphin 
(10 mg/ml; Sigma, Sf. Louis, Mo.) and incubated for I hat 3TC. The subsequent isolation and 
purification of DNA was perfonned with 4 M guanidine-isothiocyanate and Cclite according 
to previously described procedures (II). The DNA concentration in the resulting eluates was 
estimated by gel electrophoresis tlnough 1% agamse gels in Tris-borate-EDTA (TBE) buffer, 
containing ethidium bromide, and in comparison with samples containing a known amount of 
bacteriophage lambda DNA. PCR-based DNA fingerprinting analysis was perfonned with 
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primer ERIC2: AAGTAAGTGACTGGGGTGAGCG and primer I: GGTTGGGTG-
AGAA TTGCACG IO• The PCR mixtures consisted of 10 mM Tris-HCI (PH 9,0), 50 mM KCI, 
2.5 mM MgCI2, 0.1 % gelatin and I % Triton X-IOO, 0.2 mM each deoxyribonucleotide 
triphosphate, 0.2 U Taq DNA polymerase (FIT-Biotechnology, United Kingdom) and 50 pmol 
of the individual arbitrary primer was added. PCR involved 40 cycles of denaturation, 
annealing and DNA chain extension (I min at 94°C, I min at 25°C and 2 min at 74°C) in a 
Biomed model 60 thernlOcycler. Amplified DNA was separated by gel electrophoresis (3 h, 
100 mA constant current) in I % agarose, containing ethidium bromide, and photographed. 
The resulting banding patterns were interpreted visually by two independent observers. The 
combined banding patterns of both AP-PCR tests performs (ERIC2 and primer I mediated) 
were used to identify novel genotypes, which were encoded by letter; the use of capital or 
lower case letter in the resulting schemes is of 110 particular significance. Differences in band 
staining intensities were neglected, as were single band differences. 
RESULTS 
Microbiology: In total, 616 isolates of S. allrells were obtained from six pairs ofCF siblings 
and six umelated CF patients over a period of 5-148 months (median 82) of which 189 were 
available for genotyping. The median age at onset of colonization, as detennined by the first 
positive culture was 13.4 years (range 3 - 24). All S. allrells strains were methicillin sensitive 
and, if necessary, CF patients were treated with intra-venous flucloxacillin. This antibiotic 
treatment was administered two to four times per annum. This type oftreatment will affect the 
microbial flora of the individual CF patient, but data described in this communication (see 
below) emphasize the fact that this type of therapy does not eradicate entire S. al/rellS 
populations from the CF lung. Other microorganisms isolated from the CF patients included 
: Haemoplzilus Illjluellzae, Candida alb/cans, AspergillUS/lim/galus, Escherichia coli, Proteus 
mirabilis, Streptococcus plJeunloniae, StellotroplzomOIlGS malta ph ilia and Elllerobacler 
species. Patients 3, 6, 8, 16 and 17 were mainly infected with H. ilif!uel/zae. Patient 5 was 
chronically colonized with E. coli (Tables I and 2). 
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Genetic homogeneity of the S. IIl1rellS populations: In general, no differences in 
morphotypes were observed upon primary cultivation of S. aureus from CF sputum samples 
(see below for a single exception). Similarly, all 10 S. aureus colonies selected from cultures 
offive CF sputa, collected on different occasions from an individual patient, were genotypical-
ly identical on the basis of the AP-PCR data. Apparently, CF lungs are inhabited by clonal 
populations of S. aureus. 
S. allrellS colonization patterns in unrelated CF patients: In group I, several dynamic S. 
allreus colonization patterns were seen (Figure I). From patient I, five different genotypes (t, 
ll, J, K and L) were isolated during the early years of colonization. After 29 months of 
colonization, a sixth and final genotype (type n) established itself pennanently. Patient 4 and 
5 were colonized with one dominant genotype each (0 and H, respectively), but other 
genotypes were cultured on occasion (F and G twice and 0 once). Patients 2 and 6 harbored 
two (C and y) or three (H, M and I) different S. al/reus genotypes but the strains initially 
isolated disappeared and the patients became colonized long-tenn with a single genotype (H 
or I) after 25 and 77 months. Patient 3 harbored two different strains, although one genotype 
was isolated only twice, once at the beginning ofthe colonization and once at the end of study 
period after a 97 month interval. This genotype was unique for this patient and this result may 
reflect persistent colonization, although at low concentrations. Alternatively, this type might 
represent recurring environmental contaminant or a contaminant from the patients' nasal flora. 
In the intervening period another genotype, also seen in patient 4 and 5 (genotype 0), was 
isolated six times. 
S. allrells colonization patterns in pairs of siblings witb CF: In group 2, comparable 
colonization pattenlS could be distinguished (Figure 2). Colonization with one major genotype 
was seen in many afthe patients. Incidentally other strains were cultured in a sporadic nlannef, 
again mainly during the first years of colonization. Some ofthe other genotypes were isolated 
only once, except, for instance, in patient 12, where a genotype was found twice over a period 
oB months (Figure 2). Some ofthe patients harbored two major genotypes which were isola-
ted frequently ( see Figure 2, e.g. patient 8). A clear transition of the early most prevalent 
genotype (0) to another genotype (i) was noticed in patient 9, and a similar phenomenon was 
observed in patient 15 and 16. Patient 17 was colonized with one strain initially but this was 
replaced by four altemately occurring genotypes in the later stages; one genotype (a) was 
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cultured twice in the same month and two types (I and b) were cultured three times 
consecutively in a short period of time. Only three of six pairs of siblings mutually harbored 
identical strains for prolonged periods of time (pairs I, 3 and 6). In pairs 2 and 5, a strain 
carried by one of the family members was identified on a single occasion in the other patient; 
this concerns genotypes i and z. In the other three pairs, different genotypes were usually 
carried. In conclusion, for five of six sibling pairs, strain sharing was, at least on an occasional 
basis, observed; however, in some ofthe pairs the time between isolation of identical AP-PCR 
type strains was often quite long. This is true not only within individual patients (e.g. patient 
18, in whom a-type strains were isolated in 1978, and then again 10 years later in 1988), but 
also among siblings (type z isolated in patient 16 in 1987, and later, in 1992, in patient 15). 
This could be due to the lack of sensitivity of microbiological sputum analysis or very small 
numbers of bacteria present in the patients'lungs. Then again, as already discussed above, 
patients may share an environmental source of S. aI/reus. 
Thirty-five unique S. allrells genotypes were recognized among the patients described in 
this communication. From Figures I and 2 it can be observed that some of the AP-PCR typed 
isolates were present in multiple patients. However, most of the strains occurred in single 
patients only (23 out of35 types, 66%), thus giving rise to unique strain - patient combinations. 
Six types (a,b,i,z,F and G) occur in two related patients; The genotypes a,b,F and G were each 
encountered in a single, non-related patient as well. Genotypes n, C and E were each found in 
two CF patients, whereas y and H were identified in three patients. Genotype a was 
undisputably the most prevalent type; this type was found in the lungs of six out of 18 patients, 
two of whom fanned a family pair. 
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Table 1 Summary of sputum microbiology for six unrelated CF patients. 
PT G Year Total s. isolates P.aeruginosa 
of no. of aureus period number 
birth cultures number 
~ 1973 51 29 03/86-02/94 38 
2 d' 1964 68 64 02184-12/94 
3 d' 1966 97 51 10/84-02/92 63 
4 d' 1970 59 55 01184-12/94 5 
5 d' 1960 106 57 02/84-05/94 6 
6 ~ 1969 61 57 o 1184-11194 40 
isolates others species negatives culture 
period number period number period 
05/88-12194 44 03/86-06/94 09/86 
0887 14 05/85-06/94 11/91 
06/89-02192 55 11184-04/91 09/85 
10/90-01191 6 12184-03/90 10/89 
09/84-10/93 80 02184-10/94 20 03/85-07/94 
04/90-11194 20 01185-11194 07/93 
Note: Patients 3 and 6 were colonized for a long period with H. injluenzae, and patient 5 with E. coli. In most patients overlap occurred in periods of S. aureus and P. aeruginosa 
colonization. 
Table 2. Summary of sputum microbiology for six pairs of siblings with CF. 
p PT G Year Total S.aureus isolates P.aeruginosa isolates other isolates negati- isolates 
a of no. of number period number period numbers period yes period 
birth cultures number 
r 
7 ~ 1970 144 12 06/86-03/90 188 11184-01193 12 11/83-02190 9 05/84-11191 
8 d' 1973 60 32 11184-10/92 50 04/91-11194 22 11184-10/92 0 
2 9 ~ 1982 63 44 04/85-08/94 25 07/91-08/94 14 10/84-08/94 2 05/86-04/89 
2 10 d' 1980 48 12 01188-09/94 13 09/84-09/94 12 09/84-04/94 19 07/84-06/94 
3 11 ~ 1974 165 14 05/87-10/89 226 12/83-03/94 13 08/83-04/91 3 12/83-10/89 
3 12 ~ 1978 73 16 03/86-01/95 97 04/84-12/94 2 10/86-05/87 4 11/90-12/90 
4 13 ~ 1967 135 24 04/85-11189 151 10/86-09/94 13 04/85-12190 21 01/84-02/91 
4 14 d' 1962 24 25 09/85-12/94 0 8 01191-11194 11190 
5 15 ~ 1977 12 9 11184-12/93 09/89 4 02192-12/93 2 10/87-09/90 
5 16 d' 1972 41 24 11/84-12/94 6 01185-02/88 19 03/81-12/94 3 01185-03/88 
6 17 d' 1971 101 71 01185-12189 2 01185-09/88 70 01185-05/89 9 07/85-11/89 
6 18 ~ 1973 19 19 01178-03/91 0 17 01185-05/90 10/88 
Note: Patients 8, 6 and 17 were colonized for extended periods with H. injluenzae. In most patients overlap occWTed in periods of S. aureus or P. aeruginosa colonization. 
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Figure 1 Longitudinal survey of Staphylococcus aureus genotypes in 6 unrelated CF patients. 
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Note: Each genotype is characterized by a capital or small letter. A small dot in the patient related lines corresponds with a period of one month. 
Figure 2: Cultivation of different Staphylococcus aureus genotypes in 6 pairs ofCF siblings. 
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involved was .isolated twice in the same month: a point on the horizontal, patient related lines indicates a period of one month. 
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DISCUSSION 
In general, staphylococci are cleared from the respiratory tract by enclosure within the mucous 
gel and ciliary action. In CF, the mucus changes in viscosity and this lead to enhanced 
possibilities for staphylococci to successfully achieve long-tenn colonization. It has been 
suggested that other changes in micro environment such as elevated levels of inducing 
compound, e.g. calcium or mucin (12), may increase staphylococcal adherence. In the present 
longitudinal study most CF patients had periods oflong-tenn colonization by one predominant 
S. aureus genotype. The use of AP-PCR allows adequate resolution of different S. aureus 
genotypes (8,9,10). Variation in S. aurells genotypes within single patients is observed but the 
pattem is less complex compared to that was obselved previously for P. aerllgillosa (12). 
The epidemiology of airway colonization with S. allrells in CF has been investigated 
previously with the aid of pulsed-field gel electrophoresis (14). Only in 6 of34 CF patients 
colonized with S. allrells exhibited persistence of the same molecular type; in three patients 
cycles of caniage and loss of strains and appearance of new strains were observed. The 
colonization pattems found in the present study are in agreement with those observed by Bran-
cher et al (6), who used esterase identification, capsular polysaccharide typing and phage 
typing for strain tracking. Replacement of a predominant clone was seen in only five of 18 
patients. From data described in the present paper and in previous publications, it appears to 
be likely that in the individual patients' bronchial tree circumstances exist that, in combination 
with adherence (and possibly other) factors ofS. allrellS, detelmine which strain will ultimately 
colonize these patients for prolonged periods of time. 
Assuming that selection of 10 S. allrells colonies from a primary culture plate gives an 
adequate cross-sectional representation of population in the sputum, it is interesting to note that 
all colonies were apparently clonally related, if not genetically identical. The fact that no 
mixtures of strains were encountered indicates that S. allrells isolates are capable of efficiently 
excluding other, competing isolates ofthe same species. In only one culture were two morpho-
logically different types found, and both displayed an identical genotype (data not shown). 
Previous studies on H illjluellzae, in which 48 individual colonies from three primary culture 
plates of one sputum sample were analyzed genotypically, also demonstrated that all colonies 
were identical (15) . 
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In some of the six pairs of siblings, identical and persistently occurring strains were iso-
lated (e.g. genotype G in pair 3). Clearly, cross-colonization takes place in the family situation. 
This is also illustrated by the incidental occurrence of a strain that was persistently present in 
another family member. 
Identical S. allrells genotypes were found in related and unrelated CF patients, which is in 
contrast with our experience with the long-teml epidemiology ofP. aerllgillosa from the same 
CF patients (13). Genotype 0 was seen in 6 CF patients (33 %) and accounted for 20 % of all 
tested strains. Additional research is needed to demonstrate ifthis genotype is typically associ-
ated with cystic fibrosis. 
In recent literature several of the molecular features underlying S. allrells adherence were 
addressed in detail. Factors as diverse as protein A (16), fibrin or fibrinogen receptors (17) and 
receptors for various other eukaryotic cell compounds (18) have been implicated in bacterial 
colonization. The present collection of CF related S. allrells strains, both the more prevalent 
and the occasionally occurring strains, should enable the detailed analysis of staphylococcal 
features important in the establishment of a pennanently propagating population of S. aureus 
bacteria in the lungs of CF patients. 
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ABSTRACT 
Serial sputum isolates of Haemophillis ilif/lIellZae (n = 69) were obtained from eight patients 
suffering from cystic fibrosis (CF). For two of these patients all strains were analyzed for 
polymorphism in the major outer membrane protein (MOMP) profile. For all patients the 
strains were genetically characterized by random amplification of polymorphic DNA (RAPD) 
analysis. All strains were included in a survey for polymorphism inregions containing moieties 
of repetitive DNA as well. A single locus containing trinucleotide repeat units, three loci 
harboring tetranucleotides, one region comprising penta nucleotide units and two 
hexanucleotide repeat unit-containing loci were analyzed for repeat number variability. Most 
ofthe regions were previously shown to be directly adjacent to or even within virulence genes. 
All regions behaved as genuine variable number of tandem repeat (VNTR) loci in the sense 
that genetic polymorphism based on the presence of varying numbers of repeat units could be 
demonstrated among different strains. Interestingly, several ofthe repeats showed variation in 
the absence of the variability as assessed by major outer membrane protein or random 
amplification of polymorphic DNA analysis. These observations indicate that the repeat loci 
may vary independently from major chromosomal polymOlphism. Consequently, H. ilif/lIellzae 
appears to modify its virulence gene regions of the chromosome during persistent colonization 
of the lung in cystic fibrosis patients. 
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INTRODUCTION 
Cystic fibrosis (CF) is a devastating genetic disease caused by point mutations in the cystic 
fibrosis transmembrane regulator (CFTR) gene. The mutations generate a lung phenotype 
enabling persistent colonization by various bacterial species that, in tum, cause most ofthe CF-
associated morbidity and, in the end, mortality. The major CF-associated bacterial pathogens 
are Pseudomollas aeruginosa and Staphylococcus aureus, while an organism such as 
Haemophillis illfluellzae is also frequently encountered as a colonizer oflCF-affected lungs (1-
3) .. Persistent colonization with H. iJif/llellzae can be detected (4, 5), which emphasizes its 
putative involvement in CF pathogenicity. The mechanism by which H. iJif/uellzae bacteria 
cause pathogenic effects are still enigmatic, however. On the other hand, numerous virulence 
factors synthesized by H. iJif/llellzae have been identified, many of which can display 
phenotypic phase variation. The relationship between phenotype switching and pathogenicity, 
however, is still unclear and requires additional investigation. 
Phenotype switching in H. iJif/llellzae has been associated with variability at the level of 
repetitive DNA. The first gene for which this was demonstrated, lie I, appeared to be involved 
in lipopolysaccharide (LPS) biosynthesis (6). The licl vitulence gene was shown to contain 
a variable number of consecutive copies of the tetranucleotide unit (5'-CAAT-3') within the 
coding region. Variation in the overall number of repeat units moves ATG initiation codons 
in or out ofthe protein synthesis frame. Similar switches were identified in the genes lie2 and 
1ic3, found in both H. ilif/llellzae and other species of Haemophillis (7-9). Another clear 
example of DNA repeats acting as molecular switches is provided by a gene encoding a 120 
leDa haem-repressible haemoglobin-binding outer membrane protein in which a CCAA repeat 
was encountered (10). Besides the modulation of open reading frames, repeat polymorphism 
also appeared pivotal in promoter strength alternation. By changing the distance between the 
-10 and -35 consensus boxes differential gene expression could be achieved (II). 
The correlation between modulation of vimlence factor expression and DNA repeat 
variability was generalized by scanning of the whole genome sequence for H. ilif/llellzae (12) 
for the OCCUlTence of tetranucleotide repeats. It was established that these repeats were 
invariably associated with putative virulence factor-encoding genes (13). Additional studies 
revealed that other classes of repetitive DNA are also involved in the regulation of bacterial 
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pathogenicity and the possible clinical importance of this feature was emphasized (14). 
Elements like these are called variable number oftandem repeat (VNTR) loci, an abbreviation 
that will be used tln'oughout the current communication. 
The present study was undertaken in order to establish whether or not DNA repeats vary 
in the in vivo situation during persistent colonization ofCF affected lung tissue by individual 
strains of H. influellzae. This could have major implications for therapy and pathogenesis, 
since the potential to vary virulence factor expression may enable escape from inmnmity or 
chemotherapy. 
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MATERIALS AND METHODS 
CF patients and bacterial strains: Two groups ofCF patients were included in the present 
study. Two patients from the Academic Medical Center in Amsterdam, identified by the codes 
CFJO and CF32, were chosen as the source for an initial control group of strains. During the 
screening period the CF patients suffered from exacerbations caused by H. i'1!luellzae. The 
patients were intermittently treated with antibiotics. H. influellzae strains (n= I 8) derived from 
these patients were grouped on the basis of the major outer membrane protein (MOMP) 
characteristics and their genotypes were detemlined by random amplification of polymorphic 
DNA (RAPD) analysis as described previously (5, 15). From these patients, several MOMP-
identical isolates were included (n=3 strains per patient), whereas also several MOMP-diverse 
strains were selected (n=7 and n=5, respectively). The RAPD pattems were identical for all 
strains belonging to either of these patients. These strains, which were isolated between May 
1990 and January 1993, were used to survey the relatedness between DNA repeat variability 
and MOMP characteristics as an indicator of genetic relatedness or variability (see Table I). 
Subsequently, serially isolated H. ilif/liellzae strains were collected from CF patients (n=6) 
attending the University Hospital Rotterdam. The periods during which strains were collected 
were relatively long, varying between one and eight years in duration. Fifty-one strains were 
collected and analyzed with respect to overall genotype by RAPD analysis and with respect 
to more localized variation by analysis of DNA repeat polymorphism (see Table 2). 
H. illjluenzae strains were cultured from spuhnn samples which were obtained during one 
of the regular, routine check-ups ofthe CF patients. Aliquots ofthe strains were stored at -80'C 
in glycerol containing media. Prior to DNA analysis bacteria were cultured on chocolate agar 
and checked for species homogeneity. Detenllination and antibiotic susceptibility testing were 
perfonned according to standard microbiological methods (16). 
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Table I Analysis ofVNTR loci in MOMP-typcd isolates of 1l injllleJlZae colonizing the lungs of cystic fibrosis 
patients attending the Academic Medical Center in Amsterdam, the Netherlands. 
Patient Strain 
idcnt. number Hi4·3 Hi4-5 Hi4-10 Hi4-11 Hi3-1 Hi5-2 Hi6-1 Hi6-2 
MOMP identical1 
serial isolates 
CF30 14 15 14 13 26115 9 2 9 3 
CF30 16 15 II 12 24120 9 2 9 3 
CF30 17 15 II 14 26110 8 2 9 3 
MOMP variable, 
RAPD identical 
CF30 19 15 II 12 27112 9 2 9 3 
CF30 20 15 II II 25113 9 2 9 3 
CF30 21 16 10 II 25112 9 2 9 3 
CF30 22 15 II 12 31113 9 2 9 3 
CF30 23 14 10 II 31112 9 9 3 
CF30 24 16 10 II 31112 9 9 3 
CF30 25 15 13 12 31/16 9 9 3 
M01.1PIRAPD identical, 
serial isolates 
CF32 27 2 6 3 20 9 3 II 3 
CF32 28 2 6 '\ 20 9 6 II 3 
CF32 29 2 7 3 20 9 6 5 3 
M011P variable, 
RAPD identical 
CF32 30 2 7 3 19 9 5 II 3 
CF32 31 2 14 3 19 9 7 II 3 
CF32 32 2 12 3 22 9 8 II 3 
CF32 33 2 7 3 17 9 4 II 3 
CF32 35 2 7 3 18 9 6 II 3 
NB. The patients strains and genotypes have been described previously (5), the figures in the cohmms under the 
heading VNTR analyzes defme the number offepeat units present in a given locus. 
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Table 2 Analysis ofVNTR loci in serial isolates of H. injluenzae colonizing the lungs of cystic fibrosis patients attending the Academic Hospital Rotterdam. 
Patient 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
o 
w 
Strain 
96 
148 
191 
285 
287 
332 
335 
337 
338 
341 
343 
345 
350 
Iso!. date RAPD type * Hi4-3 
32985 Aa 
33392 Bb 8 
33923 Be 8 
34984 Cd 18 
35008 De 
35236 De 19 
35247 De 19 
35250 De 19 
35253 De 19 
35261 De 19 
35277 De 19 
35299 De 19 
35320 Fe 19 
Hi4-IO Hi4-11 Hi3-1 Hi5-2 Hi6-1 
10 27 8 2 6 
20 24 9 2 7 
18 31 9 4 10 
33 9 8 
25 9 8 
3 25 9 2 10 
3 25 9 2 10 
3 25 9 2 10 
3 25 9 2 10 
3 24 9 2 10 
3 24 9 2 10 
3 24 9 2 10 
3 24 9 2 10 
Hi6-2 
2 
2 
4 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
-0 
""-
Patient Strain Iso1. date RAPD type * Hi4-3 Hi4-10 Hi4-11 Hi3-1 Hi5-2 Hi6-1 Hi6-2 
V 108 33055 Bf 26 15 39 9 10 3 
V 112 33120 Ge 16 21 41 9 6 9 8 
V 143 33342 !Jg 31 2 21 9 8 9 
V 227 34575 Ie 16 3 33 9 2 10 3 
V 274 34934 Be 16 13 40 9 9 10 
V 291 35010 Je 16 13 37 9 9 3 
V 346 35310 Be 22 3 21 5 8 3 
H 39 32537 Kh 8 15 28 9 2 9 
H 40 32551 Lh 8 15 28 9 2 9 
H 49 32756 Mi 21 16 >50 9 7 10 3 
H 81 32943 Mi 21 15 >50 9 10 10 3 
H 93 32979 Mi 21 15 >50 9 10 10 3 
H 111 33118 Mi 21 15 >50 9 10 10 3 
H 126 33176 Mi 25 12 >50 9 9 10 3 
H 141 33335 Mi 24 12 >50 9 8 10 3 
H 146 33378 Mi 25 14 >50 9 11 10 3 
H 152 33419 Mi 25 14 >50 9 11 10 3 
H 192 33923 Ni 28 3 15 9 4 9 2 
H 281 34831 Ni >40 14 20 9 6 10 7 
Patient 
G 
G 
G 
G 
G 
G 
G 
T 
T 
T 
T 
T 
T 
o 
'" 
Strain 
II 
48 
68 
87 
105 
305 
314 
72 
97 
170 
221 
262 
326 
Isol. date 
32300 
32698 
32894 
32952 
33041 
35138 
35151 
32911 
32986 
33632 
34430 
34794 
35207 
RAPDtype * Hi4-3 
Li 16 
Lj 25 
Lk 25 
Lj 25 
Lj 25 
Lj 
12 
Xj 6 
Xk 6 
SI 25 
Xm II 
Sm 11 
Sm II 
Hi4-10 Hi4-11 Hi3-1 HiS-2 Hi6-1 Hi6-2 
3 29 9 9 2 
12 25 9 10 4 
12 26 9 10 4 
11 27 9 10 4 
II 26 9 10 4 
15 28 9 10 4 
11 28 9 6 0 4 
II 18 9 4 14 6 
2 30 9 8 13 
22 30 9 7 8 2 
25 >45 9 2 8 2 
24 >40 9 >40 8 2 
24 >40 9 >40 8 2 
0 
'" 
Patient Strain Iso1. date RAPD type * Hi4-3 Hi4-IO Hi4-Il Hi3-1 Hi5-2 Hi6-1 Hi6-2 
K 42 32554 Li 3 31 32 9 2 10 4 
K 79 32924 Xm 2 2 31 9 3 10 4 
K 181 33678 Pk 5 9 6 8 10 
K 272 34896 Pj 7 28 16 9 2 9 2 
K 300 35101 Qj 8 29 17 9 9 2 
K 339 35254 Rj 9 2 32 9 2 10 10 
NB °RAPD analysis was perfonned by two peR assays employing the ERlC 1 and ERIe2 primer, respectively. The two letter code describes the interpretation of the separate 
assays in one combined genocode. >: fragment too large to be accurately sized by agarose gel electrophoresis. 
VNTR sizes highlighted in bold were detennined by DNA sequence analysis. ~, not determined 
CHAPTER 6 
DNA isolation and PCR mediated typing sh,ldies: After overnight growthH. illfluellzae cells 
were harvested directly into a gnanidinium isothiocyanate containing lysis buffer (17). Celite 
(Janssen Pharmaceuticals, Beerse, Belgium) was added to the resulting lysate and further 
processing for DNA purification by affinity chromatography took place. The DNA 
concentration was detennined and the solution was stored at a DNA concentration of I a ng/f,I'! 
at -20'C. Random amplification of polymorphic DNA (RAPD) analyzes were perfonned as 
described previously, using a combination of primers ERICI and ERIC2 (15). RAPD 
fragments were analyzed by gel electrophoresis in 2-3% agarose gels (Hispanagar, Sphaero Q, 
Leiden, the Netherlands) run at 100 rnA constant current for 3 h. 
Amplification of VNTR regions was done according to recently developed protocol (14). 
The tetranucleotide VNTR loci Hi 4-3, 4-5, 4-10 and 4-11, present in different potential 
virulence genes, were analyzed, together with the trinucleotide VNTR Hi 3-1, the 
pentanucleotide VNTR Hi 5-2 and the two hexanucleotide VNTRs Hi 6-1 and 6-2 (see Table 
3 for general description and VNTR codes and PCR primers). Due to the small size of the 
VNTR amplicons and the required 3-6 nucleotide resolution, these DNA fragments were 
separated by length on 3% MetaPhor agarose (FMC Bioproducts, Biozym, Landgraaf, the 
Netherlands). Molecular sizes were detennined with the help of 10 basepair ladder 
(Boehringer-Mannheim, Mannheim, Germany). Gels were run in 0.5xTBE buffer at a constant 
voltage of 100V. Gels were photographed using a CCD camera equipped with a Fujinon zoom 
lens. Data were collected and thermo-printed using the Visionary Photo Analyst system 
(FotoDyne, Progress Control, Waalwijk, the Netherlands). 
VNTR cloning and sequencing: For cloning and sequencing, PCR amplified DNA fragments 
were purified using Qiaquick Column chromatography (Westburg, Leusden, The Netherlands). 
The amplicons were cloned into pCRl (Invitrogen, Leek, the Netherlands) according to the 
manufacturer's instmctions. Clones were analyzed with respect to the size of the insert and, 
when correct, sequenced using cycle sequencing technology and an ABI373 automated 
sequencer (ABI, Warrington, Great Britain). Sequence data were edited to the appropriate 
format using 373 Software. 
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Table 3 Survey of some of the VNTR regions encountered in the genome of H. injluenzae Rd and monitored for polymorphism in serial isolates from lungs ofCF patients. 
Repeat Repeat Repeat Unit Unit Function Primers for VNTR amplification 
until Code Position Seq Number 
Length 
5' 3' 
3 Hi3-1 291617-291644 ATT 9 not knO'Wll CAAATGATTATAAATAAACC TAATTAAAAAGAGGAGAATG 
4 Hi 4-3 570800- 570892 CAAT 23 LPS CCTCTTATATTATGTAAT TTTAGTTTCTTTAATGCG 
4 Hi 4-10 1543152-1543252 TTGC 25 adhesin GACAGATGAAAAGAAAAGAT TATAATATGTTTTATTACAA 
4 Hi 4-11 1608031-1608099 CAAT 17 LPS TAAAAATGAATACAAAA AAGTTTTAACAAATCCTACA 
5 Hi 5-2 1368890-1368910 CTCTC 4 not known GTGATTTTTATCGACAATCT TACAGAGGGCATAATTTATG 
6 Hi 6-1 283097-283115 CTGGCT 4 not known TCTACAATTTCTTGTTTTTC ATGGTGTTGGAAGAACCTGC 
6 Hi 6-2 296053- 296071 GGCAAT 3 not knO'WIl AGATTTAGAGAGAATCAGTG CGTCTTTTAGTTTACGGGTA 
Notc: The columns describing the possible gene function is derived from reference (13); repeat positions are identified on the basis of sequences presented in (12). Primers 
for the Hi 6-1 repeat are located morc distantly from the core units (see section 3). 
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RESULTS 
VNTR sequencing: DNA sequencing for some randomly chosen PCR products (see Table 2, 
bold figures) was employed to verifY the number of repeat motifs as deduced on the basis of 
the agarose gel electrophoresis and to confirm the sequence of the repeat units. Differently 
sized VNTR PCR products (Hi 4-3, Hi 4-10, Hi 4-11, Hi 3-1 and Hi 6-2), obtained for the 
strains isolated from patient V from Rotterdam, were processed. Amplicons obtained with the 
Hi 6-1 PCR and the Hi 5-2 PCR were not cloned and consequently not analyzed with respect 
to the precise sequence of the unit motif. All sequence data were in agreement with the 
consensus unit motifs as described in Table 3. Furthennore, assessment of the number of 
repeats as present in each amplicon corroborated the figures as deduced from the PCR 
fragment length detennination by agarose gel electrophoresis. VNTR sizes detennined by 
sequence analysis are highlighted in bold in Table 2. During the VNTR analyzes performed 
for the clinical isolates, sometimes band doublets were observed (see below and Table 1-3). 
This possibly indicates the existence of multiple alleles for the same VNTR locus in a single 
strain of H. influenzae. 
Analysis of MOMP typed strains from CF patients from Amsterdam: MOMP diverse 
strains shown VNTR length variability in all loci monitored except for Hi 3-1 and Hi 6-2 (see 
Table I). Variation in Hi 5-2 is only documented for patient CF32. Altogether, two sets of 
strains having identical MOMP characteristics were studied. For patient CF30 it can be seen 
in Table I that variation occurs in two out of three tetranucleotide VNTRs assayed and Hi 3-1. 
Hi 5-2, Hi 6-1 and Hi 6-2 do not seem to be variable. For the strains from patient CF32 
variability was documented for Hi 5-2 and 6-1. In conclusion, all of the VNTRs show 
polymorphism, despite the fact that they may be present in MOMP- and RAPD-identical 
strains. Some of the VNTRs differ in one patient, but remain unaltered in the other, showing 
dependence on the individual that is colonized. Among strains isolated from a single patient 
the variability in size is generally smaller than the variability seen upon analysis of strains 
derived from different patients. 
Analysis of serially isolated strains derived from patients from Rotterdam: Among these 
strains again Hi 3-1 was present as a reiatively stable genetic marker: inneariy all cases (except 
one) the number of repeat units is nine (see Table 2). Furthennore, if overall genetic diversity 
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is detennined by RAPD, associated variability among the VN1Rs is encountered. Among these 
strains even Hi 6-2 presents as a genuine VN1R (see data obtained for strains from patient K). 
An more important feature ofthis collection of strains is the fact that serial isolates, sometimes 
spanning many years, are included. This is documented by identical RAPD identification codes 
(Table 2). For patients V, T and G paired strains of identical genotype but different isolation 
data are available. In these cases clear polymorphism in various VNTRs have been docu-
mented. On the other hand it is interesting to note that other situations can also be observed: 
in patient T two strains harbor the RAPD type Sm (numbers 262 and 326). Here the VNTRs 
have remained unchanged. For patient H nine strains with RAPD type Mi were available. 
Multiple changes in VN1Rs Hi 4-3, Hi 4-10 and Hi 5-2 became apparent. The otherVNTRs 
were stable during the entire screening period. For patient N eight strains sharing genotype De 
were retrieved. Only the first isolate (strain 287) differed with respect to the VNTR 
composition. However, this isolate was cultured one year prior to the other ones, which were 
collected upon different occasions during a two months period. Moreover, for patient H strains 
192 and 181 share an RAPD pattern Ni, whereas the VNTRs are clearly different. In 
conclusion, various degrees ofVNTR size variability can be documented by peR when a given 
patient is colonized for prolonged periods oftime by a single genotype of H. illfluellzae. The 
VNTRs Hi 3-1, Hi 6-1 and Hi 6-2 are relatively constant in size, although incidental 
differences can be detennined. Most VN1Rs assayed here appear to be variable, independent 
of the stable genetic background that they are part of. 
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DISCUSSION 
Various repeat regions built from di- to hexanucleotides were identified in the full genome 
sequence for the H. influenzae Rd strain (12, 14, 18). For all of the 3-6 nucleotide repeats in 
the H. ilif/uellzae chromosome, speeific PCR test capable of detecting allelic polymorphism 
were designed (14). The length ofthe VNTRs was a stable genetic marker for separate colonies 
derived from a single clinical specinten or strains passaged in the microbiology laboratory for 
several weeks on chocolate agar plates. When several strains isolated ifom different patients 
during an outbreak oflung disease caused by H. ilif/uellzae were analyzed (15), increased but 
limited variation was encountered in the four-nucleotide unit VNTRsites (19). It appeared that 
the tri-, penta- or hexanucleotide VNTRs were more stable in nature and consequently more 
suited for epidemiological studies. One of the two five-nucleotide VNTRs, however, proved 
to be hypervariable when strains isolated during a local outbreak of H. ilif/uenzae infections 
were studied (14). 
All tetranucleotide VNTRs appeared to be assoeiated with bacterial virulence genes and 
molecular knock-out of one ofthese genes resulted in attenuated virulence (13). The nature of 
these genes varied from the well-known LPS biosynthesis genes, adhesin and glycosyltrans-
ferase encoding genes to several iron binding protein genes. It is demonstrated that during 
persistent colonization ofCF lung tissue by genetically homogeneous clones of H. ilif/llenzae, 
serially occurring alterations in VNTR lay-out can be observed. These changes do affect the 
coding potential ofthe genes in which the repeats are located: frequently the variable numbers 
of repeats encountered cover all three theoretical reading frames. Apparently, different waves 
of sub-clones of H. ilif/uellzae develop, where these sub-clones share an identical whole 
genome organization but differ with respect to the composition of their virulence gene 
repertoire. It should be realized that an entire population of bacterial cells is replaced by a 
'new' one, most probably as a result of the subtle interplay between bacterial contingency 
behavior and human defense mechanisms. It is interesting to note that besides the repeat-
assoeiated variability, H. ilif/llenzae strains that persistently colonize the lungs of CF patients 
can also vary metabolic enzyme activities. It has been documented that changes in biotypes in 
genetically constant strains occur with relative ease and irrespective of variation occurring in 
the major outer membrane protein (12). It has to be emphasized, however, that final 
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conclusions can only be drawn once these latter studies have been complemented with 
somewhat more detailed DNA sequencing studies. 
The general conclusion of the present data is that during persistent colonization of CF 
tissue H. illjlllellzae displays complicated population dynamics. Strains can be replaced by 
different genotypes (see also (5) for instance), but also within the genome of a single, 
persisting strain stlUchual changes leading to adaptation of virulence factor expression can 
occur. It is this kind of contingency behavior that may facilitate subclones to replace ancestral 
strains. The micro· environment within the CF lung may facilitate selection of this type of 
subclones and predispose the patient to those strains that are optimally adapted to the CF niche. 
The notion that many bacterial species may be capable of employing repeats for adaptation of 
their vimlence gene potential is a challenging one (20). TIlls should stimulate additional 
clinical studies to be undertaken. 
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ABSTRACT 
The nature of the micro-flora present in sputa of six different cystic fibrosis (CF) patients was 
assessed using routine microbiological culture and molecular methods. Bacterial genes for the 
small sub-unit ribosomal RNA (ssu rDNA) were specifically amplified from DNA extracted 
from the sputum samples, cloned and characterized by hybridization and DNA sequencing. A 
large number of clones from 6 sputa were screened. Initially, oligonucleotide hybridization was 
perfonned with five probes, specific for Gram-positives and Gram-negatives in general and 
the main pathogens for the CF patient (Staphylococcus allreus, Pseudomollas ael'llgillosa and 
Haemophilus itif/uellzae). For a single sputum sample, the results were fully congruent when 
culture and molecular methods were compared. In the other five sputa, discrepancies for S. 
allrells and/or H. itif/uellzae were documented. Although S. allreus DNA and H. ilif/llellzae 
DNA was detected in three and four sputa, respectively, strains could not be cultured. Although 
the peR approach is not capable of distinguishing viable from dead bacteria, all of the CF 
patients had a history of S. aureus infections, while one ofthe CF patients once had cultivable 
H. ilif/uellzae in the sputum as well. A number of clones for probe-unidentified Gram-negative 
or Gram-positive bacterial species were further analyzed by sequencing and additional 
potential pathogens were identified. Although routine culture of sputum frequently points to 
mono-specific exacerbations, our molecular data indicate that the other CF-related pathogens 
appear to be persistently present as well. We conclude that routine culture for bacterial 
pathogens from CF sputa yields limited microbiological information since it frequently fails 
to identify a number of pathogenic bacterial species that are potentially present in a viable 
status in the lungs of these patients. 
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INTRODUCTION 
Cystic Fibrosis (CF) is the most common autosomal recessive genetic disorder in North 
Europeans. The major clinical problem of CF patients is the progressive loss of pulmonary 
function, usually due to bacterial infections that contribute to an ultimately fatal lung disease. 
Staphylococcus aureus andHaemophilus illfluellzae are the most common bacterial pathogens 
early in life, Pseudomollas aerugillosa is usually encountered in older CF patients. Previous 
longitudinal studies showed that most CF patients had periods of long-term colonization by 
one predominant S. aureus genotype, but variation in S. aureus genotYpes within single 
patients was also observed (1). When the CF patients became colonized withP. aemgbwsa, 
the same results were seen, namely long-term colonization by one or two genotypes (2). Ifthe 
CF patient was colonized with H. bif/uellzae, different strains were isolated from a single 
sputum specimen and a predominant strain persisted over time (3). Initially, CF patients are 
colonized with nOllRmucoid P. aerugillosa strain. After a while, the P. ael'ugillosa strains start 
producing an extra· cellular alginate polysaccharide and their colonies on agar become mucoid. 
The presence of mucoid P. aerugillosa may obscure recognition of S. aureus. Moreover, it also 
has been documented that P. aerugillosa is capable of producing substances that inhibit the 
growth of S. aureus (4). So far, there are no pseudomonal compounds identified that impair 
the growth of H. ilif/uellzae. These observations substantiate the notion that bacterial 
colonization of the CF lung is a dynamic process. Additional investigations into the 
interactions between patient and bacteria and between different species of bacteria are still 
required. 
In order to analyze the bacterial population dynamics and complexity in the CF lung, 
improvements in microbiological diagnostics are mandatory. Shortcomings of the current, 
straightforward microbiological sputum analysis have been suggested in the past and efforts 
to improve the methodology have been documented in the literature (5, 6). However, none of 
the present procedures can guarantee exquisite sensitivity due to features like bacterial 
interference or the hardly detectable presence of metabolically and physiologically altered 
bacterial cells such as the small colony variant of S. aI/reus (7). DNA-based diagnostics can 
circumvent these problems simply, due to the fact that DNA isolation from sputum samples 
is experimentally simple and is not negatively affected by bacterial viability, competition for 
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nutrients or the presence of growth inhibitory compounds. Various strategies have been 
described for assessing the presence of mixed bacterial populations of unknown species in 
different ecological niches. ThePCR -based amplification of ribosomal genes, for instance, has 
revealed bacterial population complexity in various clinical syndromes such as dento-alveolar 
abscesses in adults (8) or necrotising enterocolitis in preterm infants (9). It was also used for 
detection of bacterial DNA in the middle ear effusions of children suffering from otitis media 
(l0). During the present study we have applied PCR amplification of a fragment of the 
bacterial small subunit ribosomal DNA (ssu rDNA), random cloning of amplified DNA and 
probe-mediated or DNA sequencing-based identification of individual clones for assessment 
of bacterial population heterogeneity in sputa obtained from CF patients. The aim ofthis study 
is to detennine the presence of the major pathogenic species H illjluel1zae, S. alireliS and P. 
ael'llgillosa in long-term colonized CF patients with molecular methods and to compare the 
results with standard microbiological culture. 
MATERIALS AND METHODS 
Patients and clinical specimens: Sputum samples were obtained from six patients with CF 
in October 1996 in the Erasmus University Medical Center Rotterdam (The Netherlands). The 
nature ofthe antibiotics used by the CF patients at the time of collection is mentioned in Table 
2. The age of the patients ranged from 21 to 32 years. All of the patients were taking part in 
the CF surveillance system that is applied in our hospital. Although the same culture 
procedures were not always used over the years, with the use of the available strains and 
clinical data, the longitudinal colonization pattern ofthese CF patients could be assessed from 
the beginning of the colonization until October 1996. The period of surveillance varied from 
4 up to II years. Patient I was colonized with S. aurells since 1990 and P. aerugillosa was 
isolated sporadically since. Patients 2 and 5 were persistently colonized with P. ael'llgillosa and 
S. alireliS was isolated once in 1988 and in June 1996, resp. Patient 3 was colonized with S. 
alireliS and P. aerllginosa since the end of 1992. Patients 4 and 6 were initially colonized with 
S. awells and after 5 and 4 years, respectively, they became colonized with P. aerllginosa as 
well. H. influenzae was isolated only from patient I, sporadically in /991 and 1992. 
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Microbiological culture techniques: Portions of sputum were washed three times in 
physiologic saline solutions. A small portion of sputum was transferred to petri dishes 
containing saline and shaken for approximately I min each. Without prior mucolytic treatment, 
the sputum sample was split in half, one portion was used for DNA isolation (see below) and 
the other half was used for routine culture. Gram-staining was used to quantify leucocytes, 
erythrocytes and bacterial content of the sputa (see Table 2). Sputa were inoculated on 
Columbia agar for detection of Gram-positive cocci, on MacConkey agar (37'C with CO, for 
24 h and without CO, another 24 h) for Gram-negative rods and on <;llOcolate agar without 
bacitracin (37'C with CO, for 48 h) for H. illjlllellzae. Phenol malllitol salt agar (37'C with 
CO, for 24 h and without CO, another 24 h) was employed for the detection of S. GllI'ells. All 
growth media were purchased from Becton Dickinson (Heidelberg, Germany). Different 
colonies growing on the various media were identified by standard microbiological testing 
(II). 
DNA isolation: DNA was isolated from CF sputum samples (5-10 mg) through a protocol that 
started with an initial lysis procedure employing SDS and proteinase K (12). After 30 minutes 
of incubation at 37'C all biological material was lysed by addition of a buffer containing the 
chaotropic agent gnanidinium isothiocyanate and the detergent Triton X-100. DNA was 
subsequently purified by affinity chromatography on Celite (JanssenPhannaceuticals, Beerse, 
Belgium). The DNA concentration in the stock solutions was detennined by agarose 
electrophoresis where samples of the DNA were run in parallel with known amounts of 
bacteriophage lambda DNA that served as references. Stocks were stored at -20'C. 
PeR-mediated DNA amplification and cloning: Amplification ofssu rDNA was performed 
according to Greisen et al (13) and by use of the universal primers DG74 and RDR080 (5'-
AGGAGGTGATCCAACCGCA-3' and 5'-AACTGGAGGAGGAAGGTGGGAC-3', 
respectively). The location of these primers on the ribosomal consensus sequence is defined 
by positions 1522-1540 and 1170-1189, respectively. Consequently, an amplimer of 
approximately 350 bp in length was synthesized. The amplimers thus obtained were randomly 
cloned into the plasmid pCRI using the original TA cloning kit version E (Invitrogen, Leek, 
The Netherlands) (14). After ligation, the recombinant plasmids were transformed into 
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competent Escherichia coli JM109 cells. For each sputum sample, a variable number of 
ampicillin-resistant transfonnants, further identified by a white color on LB agar containing 
IPTG and X-gal, were selected for analysis. 
Molecular identification ofssu rDNA clones: Individual clones were transferred to fresh LB 
agar containing ampicillin and after ovemight growth at 37'C single colony lifts were prepared 
onto Hybond N' filters. The resulting dot blots were initially analyzed by specific hybridization 
with radioactively labeled oligonucleotide probes recognizing ribosomal clones from either 
Gram-negative or Gram-positive bacteria (5' -GACGT AAGGGCCA TGACTTGACGTC-3' and 
5'-GACGT AAATCATCATGCCCCTT ATGTC-3', respectively (13). The probes were labeled 
at the 5' terminus using T4 kinase (Boehringer-Mannheim, Mannheim, Gennany) and y_32p 
labeled ATP (Amersham, Buckinghamshire, England). Unincorporated nucleotides were 
removed by gel filtration using spin columns. Hybridization was perfonned at 50'C at high 
stringency. Clones that did not hybridize with one ofthe Gram-probes or hybridized with both 
were excluded from further evaluation. Subsequently, the blots were hybridized to H. 
influenzae, S. aureus and P. aeruginosa specific DNA oligonucleotide probes (5'-
OGAGTGGGTTGTACCAGAA TAGA T -3', 5'-GCCGGTGGAGTAACCTTTT AGGGAC-3' 
and 5'-CGTGAA TCAGAA TGTCA -3', respectively (13). TheP. aeruginosa probe was newly 
developed on the basis of sequence comparisons among related species (see Table I for 
comparison and probe sequence). In order to enhance the specificity oftheH. illfluenzae probe, 
which initially cross-hybridized toP. aeruginosa clones as well, we had to modify its sequence 
to 5'-TACCAGAATAGATAGCT-3'. This probe did not show any cross-hybridization to the 
P. aerugillosa clones (unpublished data). Assessing the precise specificity ofthe probe has not 
been pursued because of the assumption that the specificity would be similar to that of the 
probe described by Greisen et al (13). The probe did not detect homologues in other sequences 
available in the GenBank database. In order to confirm the nature of the clones thus identified, 
several of them were sequenced using the Prism Ready Reaction Dye Di-deoxy terminator 
cycle sequencing kit (Amersham Int pic, Gouda, The Netherlands). Plasm ids used as templates 
for the sequencing were purified according to Bimboim (15). In addition, several clones 
positively identified as containing an insert hybridizing with either the Gram-positive or the 
Gram-negative confinnation probe and none of the species-specific oligonucleotide probes 
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were sequenced as well. Sequencing products were analyzed on an ABI373 DNA sequencer 
using the software as supplied by the manufacturer (ABI, Gouda, The Netherlands). For 
sequence comparisons and identification of ribosomal motifs, BLAST searches were 
performed against the nucleotide sequence data available from various databases (16, 17). 
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Table 1 Comparative analysis of the rRNA region for various species including Pseudomonas aeruginosa: development of a novel molecular probe for specics·specific 
identification of P. aeruginosa 
Species rDNA sequence 
11341 11351 11361 11371 11381 
Pseudomonas aeruginosa GTCGGAATCG CTAGTAATCG TGAATCAGAA TGTCACGGTG AATACGTTCC 
Pseudomonas fluorescens GTCGGAATCG CTAGTAATCG .QGAATCAGAA TGTCQCGGTG AATACGTTCC 
Acinetobacter baumanii GTCGGAATCG CTAGTAATCG .QGQATCAGAA TG.QCQCGGTG AATACGTTCC 
Bordetella bronchoseptica GTCGGAATCG CTAGTAATCG .QGQATCAGCA TGTCQCGGTG AATACGTTCC 
Burkholderia cepacia GCTGGAATCG CTAGTAATCG .QGQATCAGCA TG.QCQCGGTG AATACGTTCC 
Neisseria gonorrhoeae GTCGGAATCG CTAGTAATCG CAGGTCAGCA TACTGCGGTG AATACGTTCC 
Acinetohacter Iwoffii GTCGGAATCG CTAGTAATCG .QGQATCAGAA TG.QCQCGGTG AATACGTTCC 
Note: The actual probe sequence is presented in bold, mismatches in the probe targct region for the other organisms are highlighted by underlining as well. Numbering indicates 
the position in the 16S rRNA gene 
Table 2 Results of the detennination of the microflora of 6 CF sputa by cultural and molecular methods. 
Molecular analysis Routine microbiology 
Patient Gram Spccieso Number Number of Gram-stain Gram- Culture Antibiotic 
number probe evaluable quant treatment at time 
clones of collection 
+ S. aureus 80 313 (61 %) Leucocytes 2 S. aureus Flucloxacillin 
+ ?b 4 Gram~positive cocci 3 
H injluenzae 127 
P. aeruginosa 
l' 101 
+ S. aureus 138 
2 + S. aureus 138 624 (64%) Leucocytes Pseudomonas species, 2x Sulfamethoxazole+ 
+ ?b 75 Gram~negative rods 2 trimethoprim 
H. injluenzae 82 
P. aeruginosa 195 
?b 134 
3 + S. aureus 103 536 (62%) Leucocytes 3 S. aureus Sulfamethoxazole+ 
+ ?b 69 Gram-positive cocci 4 Pseudomonas species, 2x trimethoprim 
H injluenzae 0 Gram-negative rods 4 
P. aeruginosa 338 
?b 26 
tv 
w 
-N 
.. 
Molecular analysis 
Patient 
number 
4 
5 
6 
Gram 
probe 
+ 
+ 
+ 
+ 
+ 
+ 
Speciesn 
S. aureus 
?' 
H. injluenzae 
P. aeruginosa 
?' 
S. aureus 
l' 
H. injluenzae 
P. aeruginosa 
?' 
S. aureus 
?' 
H. injluenzae 
P. aeruginosa 
?' 
Number Number of 
evaluable 
clones 
100 220 (28%) 
98 
3 
4 
15 
0 260 (26%) 
0 
73 
0 
187 
9 605 (59%) 
5 
0 
451 
140 
Routine microbiology 
Gram-stain 
Leucocytes 
Epithelial cells 
Gram-positive cocci 
Gram-negative rods 
Leucocytes 
Erythrocytes 
Gram-negative rods 
Leucocytes 
Gram-negative rods 
Gram-
quant 
2 
2 
2 
2 
4 
3 
2 
Culture Antibiotic 
treatment at time 
of collection 
Pseudomonas species Ciprofloxacin 
Colistine spray 
Pseudomonas species, 3x Meropenem 
Tobramycin 
Clistine spray 
Pseudomonas species, 2x Ciprofloxacin 
Ceftazidime 
Colistine spray 
Note: The column "Gram quant" states the Gram-derived cellular quantities: 1 = 1 cell per field; 2 = 2-10 cells per field; 3 = more than 1 0 cells per field; 4 = more than 100 
cells per field. One field is a single microscopic field at 1 OOOx magnification. 2X or 3X in the column indicating the culture results means that 2 or 3 different species could 
be discriminated on the basis of difference in colony morphology. n: identification with oligohybridization; b: no identification with one of the species specific probes. 
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RESULTS 
A total number of 5164 clones were evaluated, 2558 of which hybridized correctly with the 
Gram-probes. The results from the analysis of the sputum samples are shown in Table 2. 
Molecular analysis, using the S. atlreliS or P. aerllgillosa or H. ilif/llellzae probes, identified 
1704 clones to the species level (see Figure I for an example of the experimental output). It 
is interesting to note that among the clones from the sputum samples, relatively large numbers 
of unidentified recombinants (both Gram-positive and Gram-negative) were still present 
(n=854). A positive signal with the Gram-negative probe and no signal with the P. ae/'llgillosa 
or H. ilif/llellzae probe was found for 603 clones. A number of these unidentified clones were 
selected at random and sequenced. Seven clones were identified as H. ilif/llellzae, 13 as 
Escherichia coli, two as Klebsiella pneul1loniae, four as Pseudomonas citronellosis, two as P. 
aerllgillosa and in two instances, a homology with human artefact sequences was documented. 
A total of 251 clones gave a positive signal with the Gram-positive probe and no signal with 
the S. alireliS probe. Fourteen of these unidentified clones were sequenced, 13 clones were 
identified as S. allrells and one asS/rep/oeoeelis maeedolliells. The fact that 13 out of 14 clones 
represented S. atlreliS DNA shows a weakness of the hybridization procedure that was used for 
clone identification. The fact that clones belonging to the species that we were specifically 
searching for remained unidentified, but could be due to smaller numbers of cells in the colony 
lifts. Upon re-examination of the blots, it appeared that the signals obtained with the Gram-
probes were also weak in these instances (results not shown). Several of the clones that were 
correctly identified by the combined application of the oligonucleotide probes were re-
evaluated by DNA sequencing. All S. aurells (n=6), P. aerllgillosa (n=IO) and H. ilif/llellzae 
(n=3) probe-reactive clones displayed correct sequences. 
S. allrells was cultured from sputa I and 3. With the molecular method rONA of S. al/reliS 
was not only found in sputa I and 3 but also in sputa 2, 4 and 6. H. ilif/llenzae was cultured in 
none of the 6 sputa, but rONA of this species was identified in sputa I, 2, 4 and 5. 
Pseudomollas spp were cultured from sputa 2, 3, 4, 5 and 6. The strains were all mucoid and 
were not identified to the species level. In all the sputa, rONA of P. aerugillosa was found, 
except in sputum 5. Probably, this patient was colonized with a Pseudomonas non-aeruginosa 
species. In patient I, a single clone of P. aerllgillosa was identified. The meaning of this 
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finding is unknown, but in 1997, this patient became colonized with P. aerugillosa and S. 
alll'eliS was isolated less frequently. It must be emphasized that many more species may be 
hidden among the clones that were not studied in detail. 
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Figure 1: Dot blot assay for discrimination of Pseudomonas aerttginosa and Staphylococcus aureus clones on 
the basis of oligonucleotide hybridization. Colony lifts were prepared from 132 Independent bacterial clones and 
the resulting blot was hybridized with a probe specific for P.aerttgillosa rDNA (panel on the left) or S. aureus 
rDNA (panel on the right). The dot on position 1 a in the panel on the left identifies a P. aerttgblOsa recombinant, 
the one on position 2a ill the right panel identifies a S. aure/ls clone. At position lk for instance neither panel 
shows positive hybridization, which is indicative of the presence of all insert different from the ones for the two 
species mentioned above. 
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DISCUSSION 
In the present study, we demonstrate that routine microbiological cultivation assays perfOlmed 
on sputum samples from CF patients do not suffice and frequently do not even fully concur 
with simple tests such as Gram-staining (see Table 2). For instance in the case of sputum 4, 
between 2-10 Gram-positive cocci were observed per microscopic field. The presence of 
staphylococci is corroborated by the molecular study but culture did not give rise to growth 
of S. aureus. Also, as can be seen from the quantitative Gram-staining data, there is no 
apparent concordance between the lack of positive cultures and the amount of cells as 
identified on the basis of the Gram-staining and subsequent microscopic analyzes. In all cases, 
except for sputum 5, only one or two bacterial species were documented by culture in the 
clinical microbiology laboratory. 
Our study demonstrates for the first time the universal presence of multiple potentially 
pathogenic bacterial species in the sputum ofCF patients. This observation argues for changes 
in the diagnostic protocol. It has to be emphasized, however, that our analysis might be blurred 
by the fact that the CF patients have to follow a nearly continuous regimen of antibiotic 
consumption. Since the PCR does not distinguish between living and dead organisms, the 
comparison with culture may not be completely fair. In defense of our approach it is 
demonstrated for sputum I, for instance, that the flucloxacillin therapy, aimed at S. allrells did 
not prohibit a positive culture result. In the other sputa, viable organisms were also detected, 
despite use of adequate antibiotics as determined by culture results. These latter observations, 
together with the fact that long-term persistence of bacterial DNA in the CF lung is deemed 
unlikely, due to high levels of sputum production, suggest that we are detecting rDNA from 
viable and, consequently, potentially pathogenic bacterial populations. Although all patients 
received anti-microbial prophylaxis at the time of sample collection, some interesting 
observations can be made with respect to bacterial viability. The therapy applied with patient 
1 for instance, should not affect Gram-negative bacteria, whereas the use of coJistine spray 
should not act against S. allrellS (see Table 2, patients 4 and 6). Thus, we have to conclude that 
not all patients received effective broad spectmm therapy, which argues for the fact that the 
microorganisms detected by the molecular approach were likely to be alive at the moment of 
harvesting the clinical material. 
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The present data suggest that microbial diagnostics in CF patients may only be useful for 
assessing the nature of the pathogen causing an exacerbation. Previous studies showed that 
most of the CF patients remain colonized for a long period with an identical genotype of S. 
allrellS and/ or P. aerugillosa (1,2). This suggests that once a patient is colonized with a given 
microbial species, it will most probably persist, despite the use of anti-microbial therapy (18) 
and even though culture yields negative results. This is also a distinct possibility for those 
bacterial species that could be identified by sequence analysis of cloned rDNA fragments. For 
instance in sputum 1, E. coli, K. plleu11lolliae andH. infiuellzae could be identified on the basis 
of sequence homology searches and additional research on the putative persistency of these 
bacterial species is certainly indicated. In the past, several cases describing similar phenomena 
have been reported. Whitby et ai, for instance, detected BlIrkllOlderia cepacia DNA in culture-
negative CF sputa with a species-specific PCR. These patients were previously demonstrated 
by culture to be inteunittently colonized (19). 
The efficiency of PCR, cloning and hybridization with species-specific oligonucleotide 
probes for detection of S. allrellS, H. illfluellzae and P. aerugillosa was analyzed and compared 
to the results of microbiological culture. This demonstrated that the technically more 
demanding molecular procedure appeared to be more sensitive than cultivation. In five 
Pseudomollas spp. CUlture-positive sputa, S. allrells failed to grow in four sputa and H. 
illfiuellzae in three. Patient 2, for instance, had never been diagnosed with H. illfiuellzae, but 
only with a Pseudomollas spp. infection in the period of 10 years that she was regularly 
visiting our hospital for check-ups. In the molecular diagnostics analysis, however, 83 out of 
411 Gram-negative clones that were specified represented H. ilif/llellzae. In this group of 
patients, specific therapy aimed at a single microbial species may provide an excellent 
opportunity for one of the other species that are sub-clinically present to fill the ecological 
niche that becomes vacant upon such an occasion. True quantitative interpretation of the data 
that we provide is not feasible since the ratio observed between different species present in the 
sputa may well be different from the ratio observed between species on the basis of numbers 
of clones. It may be that a given template amplifies to a lesser (or a larger) extent. Also the 
numbers of rRNA genes per genome differ between species. If the PCR data are to be useful 
clinically in the filture, then quantification of each species within a sputum sample will be a 
requirement. 
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In conclusion, it can be stated that microbial diagnostics and therapies that are based on 
culture only are inadequate. Alternatives or suggestions for improvement of microbiological 
and clinical care arc, however sadly, hard to provide at this stage. Firstly, the molecular 
procedure described in the present conununication is far too complicated to be implemented 
in routine diagnostics. Secondly, research on the viability ofthe bacterial species identified by 
rDNA PCR only should be perfonned. Last but not least, further molecular analyzes of the 
micro-flora present in the lungs of CF patients in relation to the stages of their disease and 
therapies provided are needed to elucidate the role of micro-organisms in the pathogenesis and 
prognosis of CF. 
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GENERAL DISCUSSION 
Microbial typing studies are needed once it is suspected that a series of isolates from various 
sources are epidemiologically linked or that multiple isolates of the same species isolated 
during the course of an infection in a single patient are cIonally related. The level of cIonal 
relatedness is dependent on the nature and number of characteristics that are shared by different 
strains of a given microbial species. Typing systems are based on the premise that c10nally 
related isolates will share characteristics by which they can be differentiated from unrelated 
isolates. The utility of a patiicular characteristic for typing is related to its stability within a 
strain and its diversity within the species. Several criteria are useful in evaluating typing 
systems: typeability, reproducibility, discriminatOlY power, ease of interpretation and 
feasibility. 
For our study we compared phenotyping techniques and genotyping techniques mainly for 
Pseudomonas aerugillosa. 
Classical strain typing teclmiques are based on the presence or absence of metabolic or 
biologic activities. Such phenotyping techniques, including antimicrobial susceptibility 
profiling, pyocin sensitivity or pyocin production testing, susceptibility to phages, biotyping 
and OMserotyping have been used for epidemiological investigations of P. ael'uginosa. Each 
of these methods has its advantages and disadvantages. 
Phenotyping of P. ael'llgillosa strains from CF patients is difficult, because differing 
antibiograms can be observed in strains cultured from a single sputum sample of an individual 
patient and antibiograms may change under the selective pressure of antimicrobial therapy. 
Pyocin types are also subject to change in response to antimicrobials. It is known that a biotype 
can change during the course of an outbreak. Bacteriophage sensitivity testing of 
morphological different strains, mucoid and non-mucoid, may yield different sensitivity 
patterns. Serotyping is the most commonly applied method oftyping isolates from CF patients, 
however, up to 70% of the isolates may either be non typeable or agglutinate in multiple 0-
typing sera. Each of these methods have been effective for typing in certain clinical settings, 
but most have also been found inadequate under conditions in which P. aerugillosa undergoes 
spontaneous phenotypic conversion. 
The more recently developed molecular typing techniques such as restriction fragment 
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length, polymorphisms of bacterial genes, PCR based on analysis of (parts ot) genomes and 
nucleotide sequence analysis, have proved to be powerful tools for differentiating isolates. 
In chapter 2 we demonstrate the lower resolution of sero- and pyocin typing procedures 
when compared to DNA typing by PFGE and AP-PCR. PFGE is a variation of agarose gel 
electrophoresis in which the orientation of the electric field across the gel is changed 
periodically. This enables DNA fragments as large as mega bases to be separated effectively 
on the basis of their size. 
AP-PCR, also referred to as RAPD, is based on the use of short primers whose sequence 
is not directed to any known genetic locus but will nevertheless randomly hybridize 
chromosomal sites with sufficient affinity to pennit the initiation of DNA polymerization. If 
two. sites are located within a few kilobases of each other on opposite DNA strands then 
amplification of the intervening fragment will occur. 
As stated above the phenotypic procedures, used in chapter 2, displayed lower typeability 
and discriminatory power than PFGE and AP-PCR; the latter two generally showing 
concordance. A reason for the small discrepancies observed may be the lack ofstandardization 
ofthe mles applied for the description of (sub )clonal relationships based on genotyping results. 
In the literature, the definition for a PFGE subclone is based on positional differences in the 
position of up to five bands from the index type, whereas in case of AP-PCR a single band 
difference led to the definition of another type. These widely differing approaches for 
clone/subclone description may explain most of the differences encountered between PFGE 
and AP-PCR data as shown in chapter 2. 
Chapter 3 focuses on detemlination of subclonal variants P. aerllgillosa strains based on 
AP-PCR patterns in comparison with PFGE pattenlS. Typing systems such as PFGE of DNA 
macrorestriction fragments and AP-PCR analysis have been used for detailed comparisons 
among clinical and envirorunental strains of P. aeruginosa. However, only a few studies have 
been published in which the efficacies of the typing strategies were compared. The relationship 
between data obtained by PFGE and AP-PCR for the same collection of P. ael'llgillosa isolates 
was discussed. These authors concluded that AP-PCR can serve as a first screen for P. 
aerllgillosa typing for two reasons: it is rapid and it is relatively easy to apply. 
Our study as described in chapter 3 indicates that if single band differences between AP-
PCR derived fingerprints are ignored, there is excellent agreement between AP-PCR and the 
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PFGE-based grouping of P. aerllgillosa strains. Unfortunaly, both techniques have their 
limitations. PFGE has two limitations, the preparation of suitable DNA can vary in duration 
from 2 to 4 days because of the need to dim.se all buffers and enzymes into the agarose insert 
and it requires expensive, specialized equipment. Another problem is the selection of the 
restriction enzymes. The prhn31y selection criterion for restriction enzymes used for PFGE 
pretreatment should be the presence ofa sufficient number of restriction sites to allow adequate 
discrimination and resolution. AP-PCR has problems in achieving reproducible, discriminatOlY 
results because the reaction conditions during PCR are less stringent; stringency is reduced in 
order to facilitate the initiation of the polymerization reactions at sites having one or more 
mismatches. Moreover, the quantities of template DNA may vary among the different 
fragments amplified from an isolate. 
In case of P. aerugillostl, we found that the existence of as many as six differences between 
the PFOE generated DNA banding patterns may not rule out clonal relatedness. The AP-PCR 
data obtained with primer ERIC2 were interpreted in a straight fonvard manner: only single 
band differences should be ignored. This would allow the following typing scheme: by 
screening with AP-PCR clonal relatedness can be detennined rapidly, easily and at relatively 
low costs. In a second stage. PFOE could be used for confirmation of the AP-PCR data and 
for the definition of a so called libr81Y type. Libr81Y types are final and useful for establishing 
databases amenable to expansion with novel types in the future. Libr81Y typing allows for 
detailed retrospective analyzes. However, no such definite system is yet available for 
P. aerugiJlosa, H. illjlllellzae or S. alirellS, although our shldies ce11ainly allow for adequate 
evaluation of the procedures that are cunently available. Future studies using multilocus 
sequence typing or DNA chip technology will reveal the feasibility of developing library 
typing systems for the three CF pathogens of primmy impOliance. 
In the next three chapters we determined colonization patterns for the three primary CF 
pathogens: H. illjluenzae, S. aureliS and P. aerugillosa. 
In chapter 4 we present a family-band Shldy of P. aeruginosa colonization in the lung of 
CF patients in order to fi1l1her elucidate the long-term colonization and spread of P. aeJ'uginosa 
strains within the family milieu. The diversity and variability of P. aerllginos(l strains in long-
term colonized CF siblings were investigated with molecular typing using a single AP-PCR 
assay. 
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Thliby considered a patient to be chronically colonized if cultures of sputum samples 
yielded P. aerugillosa for six consecutive months and/or when two or more precipitins against 
P. aerugillosa were present in the serum. However, our study showed that detailed genetic 
analysis ofthe P. aerllgillosa isolates is needed before concluding that an infection is chronic, 
because clones frequently are lost and required, especially in the beginning of the phase of 
infection with P. aerllgillosa. It seems to be that before the lungs become persistently 
colonized with one or two stable genotypes, infections with several clones of P. aerugillosa 
will take place. 
Several studies have reported on the patterns of chronic infection, including studies on 
colonization with a singlestrain,periorlicai replacement ofa predominant strain or colonization 
with multiple, coexistent strains. Cross-infection has been documented frequently. Some of 
these discordant results may be due to methodological differences, including duration of 
follow-up and the typing method used. In our study most patients were persistently colonized 
with a single genotype of P. aerugillosa, and only a few patients were colonized with nlOre 
than one genotype of P. aerllgillosa. Cycles of carriage, with loss of strains and appearance of 
new strains were observed. Interestingly, identical genotypes were only found when strains 
isolated from CF patients in a family were compared. Between families, no overlap in 
colonizing strains was encountered. Previous studies have shown that siblings can be colonized 
with identical genotypes of P. aerugillosa. However, in our study only two out of six pairs of 
siblings acquired a genotypically identical long-tenn colonizing strain. This observation 
supports the theory that short-tenn cross-contamination between related patients may occur, 
but that such cross-contamination only rarely leads to persistence of the cross-contaminating 
strain. Ifcross-infection was the most important origin of infection in the family situation, we 
would have expected to find a higher colonization rate with identical strains in our pairs of sib-
lings. The results of our study also showed that the younger sibling did not become colonized 
or infected with P. aerugillosa in the same period as the elder one. If prolonged intimate 
contact is needed for cross-infection than we would have expected that siblings should become 
infected at more or less the same time. A number of reports have been published showing that 
a higher percentage ofCF patients treated at a special CF Center acquired P. aerugillosa earlier 
than those treated elsewhere. After separation of non-infected from infected patients and 
implementing simple hygienic precautions, a decrease in the yearly incidence of new P. 
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ael'ugillosa infection among CF patients was noted. These results are in apparent contradiction 
when compared with the sibling studies. Possibly the clinical state ofthe respiratory tract and 
the receptiveness to particular strains within the CF lung's environment are more significant 
factors for establishing long-tenn colonization than proximity alone. FU11her research about 
the clinical relevance of cross-infection needs to be done. 
Chapter 5 describes our study on the epidemiology of airway colonization with S. aureus 
in CF patients. The persistence of S. aureus in young CF patients is a well known phenomenon 
but the epidemiology has not been studied extensively. In our study most CF patients exhibited 
pedods oflong-tenn colonization by one predominant S. aureus strain and in a few patients 
cycles with several S. aurells clones were observed. Replacement of a predominant clone by 
another was also seen. Identical S. aureus genotypes were found in unrelated CF patients as 
well as in the siblings. We observed the ability of S. aureus to persist and interchange in this 
patient population. A remarkable feature is that most of the younger CF siblings become 
colonized earlier with S. aureus than the older ones. The variation in P. ael'uginosa genotypes 
is much higher than in S. aureus genotypes, indicating that S. aureus as a species is more 
clonally organized than P. aerugillosa. One genotype of S. aureus was isolated in 33% of the 
CF patients and accounted for 20% of all tested strains. This is in contrast to what we found 
in our P. ael'llgillosa study (chapter 4). Additional search for factors that can playa role in 
bactedal colonization is needed to demonstrate if this genotype is typically associated with 
cystic fibrosis. 
In chapter 6 we investigated the variation in so-called tandem repeat elements in the 
genome of H. iJif/uellzae isolated from CF patients. Vadous repeat regions consisting ofdi- to 
hexanucleotides are identified in the full genome sequence ofthe H. ilif/llellzae Rd strain. For 
all ofthe 3-6 nucleotide repeats in the H. ilif/llellzae chromosome, a specific PCR test capable 
of detecting allelic polymorphism was used. The td-, penta- or hexanucleotide VNTRs 
appeared to be relatively stable among the CF H. ilif/uellzae strains. In general, vadability in 
repeat unit numbers showed concordance with overall genome heterogeneity. However, a 
problem of this particular approach for studying epidemiology might be that repeat regions are 
susceptible to "environmental" strcss and thus are hyper variable. This may restrict the 
application of the VNTRs for molecular typing of bacterial strains but it potentially sheds light 
on virulence potential of a strain. 
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For instance, most ifnot all tetranucleotide VNTRs appear to be associated with bacterial 
virulence genes. Consequently, variation in such repeat unit numbers may affect the virulence 
gene involved: a gene is either switched on or off. The nature of these genes varies and ranges 
from the well known LPS biosynthesis genes, and adhesin and glycosyltransferase encoding 
genes to several iron binding protein genes. Our study demonstrated that during persistent 
colonization ofCF lung tissue serially occurring alterations in VNTR lay-out can be observed 
in the absence of other changes as assessed by pheno- or genotyping techniques. This 
observation indicates that the repeat loci may vaty independently from major chromosomal 
polymorph isms. Apparently, different sub-clones of H. illfluellzae develop during 
colonization. These sub-clones share the overall genome organization but may differ in their 
virulence gene repe110ire. This phenomenon is probably due to the interplay between bacterial 
replication and human defence mechanisms. The general conclusion of our study is that during 
persistent colonization ofCF tissue, H. injluenzae displays complicated population dynamics. 
Strains can be replaced by different genotypes but stmctural changes within the genome of a 
single, persisting strain can also lead to the adaptation of virulence factor expression. The 
micro environment within the CF lung may facilitate selection of this type of subclone and 
predispose the patient to those strains that are optimally adapted to the CF niche. 
A logical conclusion to the above findings is that the CF lung provides a dynamic 
microbiological environment. Strains come and go, with some persevering for prolonged 
periods. Although species diversity is observed on occasion, the majOlity of cultures only 
yield a single species in abundant quantities. This seems contradictOlY and for that reason we 
compared conventional and molecular methods for the detection of bacterial pathogens. 
(chapter 7) The yield ofPCR, cloning and hybridization with species-specific oligonucleotide 
probes for the detection of S. alirellS, H. illfluenzae and P. aeruginosa was analyzed and 
compared to the results of routine microbiological culture. This technique demonstrates for the 
first time the presence of a combination of pathogenic bacterial DNA in the sputum of CF 
patients, while the conventional methods yielded a single species only. Thus, routine 
microbiological cultures perfonned on sputum samples from CF patients do not appear to be 
sufficient and frequently do not even fully concur with findings of simple tests such as Gram-
staining. Shortcomings of the microbiological analysis by cultivation of sputum samples ofCF 
patients have been documented in the literature, especially with regard to H. illfluenzae. In 
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almost all cases only one bacterial species was documented by culture. In most of the 
Pselldomonas spp. culture-positive sputa, S. aurells and H. ilif/uenzae failed to grow. This 
observation argues for changes in the diagnostic protocol. Unfortunately, the molecular 
technique is not able to distinguish between viable and dead organisms, thus the comparison 
with culture may not be relevant. The presence of a combination of pathogenic bacterial DNA 
in the sputum ofCF patients, together with the idea that it is unlikely that bacterial DNA could 
persist in the absence of viable bacteria (note the high levels of sputum production in these 
patients), suggest that we are detecting rDNA from viable and consequently potentially 
pathogenic bacterial populations. The microorganisms detected by the molecular approach are 
likely to be alive at the moment of harvesting the clinical material. The colonization patterns 
of the CF patients were also evaluated. In most of the patients S. aurells was cultured at a 
younger age. H. ilif/llellzae was cultured only in one patient. Combined with the results from 
other aspects of our study described in previous chapters, these patterns imply that once a CF 
patient is colonized with one ofthe three pathogens, he or she will remain colonized for a long 
time despite the use of antimicrobial therapy.· Even when the pathogen is not detected by 
conventional techniques, it may still be present. Further studies for the clinical relevance of 
these findings, and whether or not they should influence therapy and prophylaxis, are needed. 
In conclusion, we suggest that current microbiological diagnostics and therapies may be 
inadequate, and thus molecular procedures should be futher developed and applied in this 
setting. 
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SUMMARY 
Cystic Fibrosis is a autosomal recessive hereditary disease, classically recognized by airway 
infection, exocdne pancreatic insufficiency and elevated sweat chloride. Early respiratory tract 
pathogens include Staphylococclis aUl'eliS and Haemophilus ilif/uellzae; Pseudomonas 
aeruginosa, particularly mucoid variants, appears in greater prevalence with increasing age. 
To study the chronic colonization pattenlS in more detail, many studies typing these pathogens, 
have been performed. Phenotyping of mucoid P. aerugillosa proved to be of limited value. 
Despite this, many epidemiological studies, using phenotyping, about the colonization of P. 
aerugillosa have been done. In contrast, little is known of colonization patterns of S. aureus 
and H. iJif/uellzae. With the 'new' molecular techniques we hoped to enhance the insight into 
the epidemiology of the main pathogens of the respiratory tract of cystic fibrosis patients. 
Before these techniques could be used, however, we first had to study which technique was 
best suited for this purpose and to detennine its discdminatory power. 
Chapter 2 descdbed the charactedstics of P. ael'llgillosa isolates pairs recovered from 29 
cystic fibrosis patients over an interval of 29 months or more. The fifty-eight isolates were 
serotyped, pyocin-typed, and subjected to arbitrary pdmed polymerase chain reaction (AP-
PCR) analysis and pulsed field gel electrophoresis (PFGE) analysis. The results indicated that 
AP-PCR and PFGE showed the greatest strain discdminating ability. AP-PCR showed an 
advantage in that all isolates were typeable while four of the 58 isolates were not typeable by 
PFGE, perhaps because of nuclease activity. Comparing the results from both DNA typing 
techniques generated 15% discordance. Overall, molecular typing techniques showed to be 
superior to phenotyping for P. aerllgillosa. In this chapter we further showed that AP-PCR is 
a fast and usenll teclmique for detennining clonality among P. ael'llgillosa isolates. However, 
the interpretation of data and comparative analysis ofPFGE and AP-PCR results necessitated 
additional (international) standardization and the development of practical guidelines. 
To resolve questions about data interpretation, chapter 3 descdbed a study of eighty-seven 
strains of P. ael'llgillosa. These strains were typed by random amplification of polymorphic 
DNA (RAPD) and PFGE. Strains were clustered on the basis of epidemiological data and on 
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the basis of interpretative criteria for the PFGE analysis, implying that separate types should 
be differing in more than six fragments. In RAPD assays using the enterobacterial repetitive 
intergenic consensus sequence ERIC2 primer, and while ignoring single band differences, 
RAPD-detennined grouping of P. aerugillosa is congruent with that obtained by PFGE. 
Consequently, RAPD can be used as a first screen in epidemiological charactclization of P. 
ael'llginosa. 
To study the epidemiology of P. aerugillosa among cystic fibrosis siblings, P. aerugillosa 
isolates from sputum samples of 6 pairs of siblings were analyzed longitudinally over a period 
of20-126 months.(Chapter 4) The isolates were analyzed by DNA fingerprinting using AP-
PCR. Two of six pairs of siblings were colonized by identical genotype. A P. aerugillosa 
genotype persisted in a CF patient for over ten years. No overlap in P. aerugillosa genotypes 
between families was encountered. The results of the study demonstrate that P. aerugillosa 
cross-infection or acquisition ofthe same strain from an identical environmental source exists 
within the family situation, but does 1I0t always result in a long-tenn colonization by identical 
genotypes in all CF family members. 
In chapter 5 the epidemiology of S. aureus colonized CF patients was studied. S. aureus 
isolates from six unrelated CF patients and six pairs of CF siblings were genetically typed by 
AP-PCR assays. In most of the patients long-tenn colonization with a single genotype was 
observed. One common genotype was found in six patients, two of whom formed a family pair. 
Identical genotypes were shared by siblings, this suggests intra-familiar transmission or the 
presence ofa common environmental source. The results of the study demonstrate that in most 
of the CF sibling pairs different genotypes of S. aureus caused the ultimate long-tenn 
colonization despite cross-infection or identical common environmental source. 
To investigate the polymorphism in variable number of tandem repeat (VNTR) loci, serial 
sputum isolates of H. ilif/lIellZae were obtained from cystic fibrosis patients (chapter 6). All 
strains were genetically characterized by random amplification ofpolymorphic DNA (RAPD) 
analysis and strains from two patients were analyzed for polymorphism in the major outer 
membrane protein (MOMP) profile. For analysis of repeat number variability, a locus could 
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contain tri- or tetra- or penta- and hexanucleotide repeat units. Most of the regions could be 
associated with bacterial virulence genes. It appeared that some of the VNTRs were more 
stable than others. Several ofthe repeats showed variation, although there were no changes in 
major outer membrane protein or random amplification of polymorphic DNA types. In 
conclusion, a persisting H. ilif!uellzae strain changes its vimlence gene regions of the 
chromosome during colonization ofthe cystic fibrosis lung, independent of the lack of major 
chromosomal polymorphism. 
It is known that microbiological cultuvation ofCF sputa is difficult because P. ael'llgillosa is 
able to suppress the growth of S. alll'eus and H. ilif/uellzae can be missed through overgrowth 
by P. aerugillosa. In this study, six sputa of different cystic fibrosis (CF) patients were 
evaluated using routine microbiological culture and extensive molecular methods (chapter 7). 
Bacterial genes for the small sub-unit ribosomal RNA (ssu rRNA) were specifically amplified 
from DNA extracted from the sputum samples, cloned and characterized by hybridization and 
DNA sequencing. Oligonucleotide hybridization was perfonned with five probes, specific for 
gram positives and gram negatives in general and the main pathogens for the CF patient (s. 
aureus, P. ael'llginosa and H. ilif/uellzae). 2558 clones from six sputa were hybridized 
correctly. For a single sputum sample the results of microbiological culture and molecular 
methods were fully congruent. In the other five sputa, discrepancies for S. aureus and/or H. 
ilif/uenzae were documented. Although S. aureus DNA and H. ilif/uellzae DNA were detected 
in three and four sputa, respectively, strains were not cultured. Unfortunaly, the PCR approach 
is not capable of distinguishing viable from dead bacteria. All ofthe CF patients had a history 
of S. aureus infections, while one of the CF patients once had cultivable H. ilif/uellzae in the 
sputum as well. A number of clones for probe-unidentified gram negative or gram positive 
bacterial species were further analyzed by sequencing and potential pathogens were identified. 
Routine culture of sputum frequently seems to be a mono-specific exacerbations, our molecular 
data indicate that the other CF related pathogens appear to be persistently present as well. 
Overall, the routine culture for bacterial pathogens from CF sputa yields limited 
microbiological infonllation since it frequently fails to identifY a number of pathogenic 
bacterial species that are potentially present in the lungs of CF patients. 
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Cystic fibrosis (CF) is een recessieve autosomale aandoening. De klassieke trias voor CF 
bestaat uit luchtweginfecties, exocriene pancreas insufficientie en verhoogde chloride 
uitscheiding in zweet. Op jonge leeftijd worden de infecties van de tractus respiratorius 
veroorzaakt door Staphylococcus OIIreus en Haemophilus injluenzae. De prevalentie van 
Pseudomonas aerugillosa infecties, vaoral veroorzaakt door de muco1de vonn, neemt toe op 
latere leeftijd. In het veri eden is met behulp van fenotypering de epidemiologie van de 
kolonisatie vanP. aeruginosa bestudeerd. Het is uit de literatuur bekend dat deze typering van 
P. aerllgillosa zijn beperkingen heefi, onder andere veroorzaakt door het mucoi'de karakter. 
Wat betreft de kolonisatie van S. aureus en H. ilif/uenzae is niet veel bekend. De opzet van de 
studie was om met behulp van de 'nieuwe' moleculaire technieken een beter inzicht te krijgen 
in de "kolonisatie" epidemiologie van de belangrijkste pathogenen van de tractus respiratorius 
van de CF patient. Echter, voordat de technieken gebruikt konden worden werd eerst 
bestudeerd welke techniek het meest geschikt was voar gebruik in de studie en diende tevens 
het onderscheidend vermogen van de technieken vastgesteld te worden. 
In hoofdstuk 2 werd de typering van gepaarde P. aeruginosa isolaten, alkomstig van 29 CF 
patienten en afgenomen met een interval van 29 maanden ofmeer beschreven. De 58 isolaten 
werden geanalyseerd door middel van serotypering, pyocine-typering en de moleculaire 
teclmieken, arbitrary prinled polymerase chain reaction (AP-PCR) en pulsed field gel 
electrophoresis (PFGE). De resultaten toonden aan dat AP-PCR en PFGE een groat 
onderscheidend vennogen hebben. Het voordeel van AP-PCR ten opzichte van PFGE was dat 
aile isolaten typeerbaar waren in tegenstelling tot PFGE waarbij 4 isola ten mogelijk door 
nuclease activiteit niet geanalyseerd konden worden. De resultaten van beide DNA technieken 
laten een discrepantie zien van 15%. Samenvattend, voor P. ael'llginosa geldt dat moleculaire 
typeringstechnieken een beter discriminerend velmogen hebben dan fenotyperingstechnieken. 
Echter, om de interpretatie van de gegevens en de onderlinge vergelijking van de PFGE en AP-
PCRresultaten te kunnen standaardiseren diende nog meeronderzoek verricht te worden zodat 
er richtlijnen voor adequate data interpretatie vervaardigd kunnen worden. 
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Om richtlijnen te maken voor de interpretatie van AP-PCR patronen werden in hoofdstnk 3 
87 P. aerugil/osa isolaten getypeerd met zowel AP-PCR als PFGE. De isolaten waren 
geclusterd op basis van de epidemiologische gegevens en op basis van het uit de literatuur 
afkomstige interpretatieve criterium voor PFGE-analyse. Dit criterium was: Iliet identieke 
isolaten verschillen in 6 ofmeer fragmenten. Met de vergelijking tussen de PFGE getypeerde 
isolaten en de gevonden resultaten met AP-PCR wordt er getracht een criterium op te stellen 
voor de interpretatie van de AP-PCR data. De AP-PCR analyse van P. aerl/gil/osa gebruik 
makend van de primer enterobacterial repetive intergenic consensus2 (ERIC2) primer bleek 
identiek aan PFGE als een verschil van 1 enkele fragment genegeerd werd. In verband met 
het experimenteel gemak en de overeenkomst tussen de AP-PCR en de PFGE data, 
gebruikmakend van het vastgesteld criterium, bleek AP-PCR een goede screeningsmethode 
voar epidemiologische onderzoek van P. aeruglnosa. 
De epidemiologie van P. /lerugil/osa alkomstig van gezinsleden lijdend aan CF werd in 
hoofdstuk 4 bestudeerd. Voorde typering van de isolaten werd gebruik gemaak! van AP-PCR. 
De P. aerl/gil/osa isola ten, gekweekt uit het sputum van 6 paar gezinsleden, over een periode 
varierend van 20-126 maanden werden geanalyseerd. Twee van de zes paar gezinsleden bleken 
gekoloniseerd te zijn met een genotypisch identieke P. aerugillosa stam. Tussell de diverse 
families is geen overdracht van P. aerl/gil/osa genotypen gevonden. In 1 CF patient 
persisteerde eenP. aerl/gil/osa genotype gedurende ruim 10 jaar. De resultaten van deze studie 
geven aan dat in een gezinssituatie kruisinfeetie enlofacquisitie van hetzelfde isolaat, mogelijk 
vanuit een gemeenschappelijke omgevingsbron, bestaat, maar dat dit niet altijd leidt tot een 
langdurige kolonisatie met identieke genotypen binnen deze gezinnen. 
In hoofdstnk 5 is de epidemiologie van S. allrells in CF patienten bestudeerd. Met behulp van 
AP-PCR werden S. allrells isolaten alkomstig van 6 I1iet gerelateerde CF patienten eIl 6 paar 
gezinsleden met CF getypeerd. In de meeste patienten werd langdurige persistentie van een 
bepaald genotype waargenomen. Een genotype werd bij zes patienten gevonden, waarvan er 
slechts 2 een familiepaar vonnden. Uitwisseling van identieke genotypen vond plaats bij 
familieleden gedurende een bepaalde tijd. Dit pleit voor een intra familiaire transmissie of 
aanwezigheid van een gemeenschappelijke omgevingsbron. De studie resultaten impliceren 
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dat de meeste gezinsleden uiteindelijk Iangdurig gekoloniseerd zijn met "hun eigen" S. aureus 
genotype ondauks potenticle kmisinfectie of een gemeenschappelijke omgevingsbron. 
Ook de epidemiologie van H. influenzae bij CF paticnten is relatief spaarzaam onderzocht. In 
Hoofdstuk 6 werd genetische karakterisering van seriele H. influenzae isolaten uit het sputum 
van 8 CF paticnten beschreven. De isolatie periode varieerde van I tot 8 jaar. De H. ilif!uenzae 
isolaten werden getypeerd middels AP-PCR. Bij 2 paticnten werd tevens gekeken naar de 
variatie in het buiten membraaneiwit (major outer membrane protein, MOMP) patroon. De 
typeringen (AP-PCR, MOMP) toonden aan dat persistentie van isolaten bij eukele paticnten 
voorkwam. Van H. iI~fluel1zae is bekend dat de regulatie van virulentie gen expressie voor een 
deel kan worden toegeschreven aan variatie in de lengte van gebieden van repetitiefDNA. De 
lengte veranderingen geven aanleiding tot verstoring van leesramen van genen of lei den tot 
aantasting van de stmctuele integriteit van promotoren. De meeste loci van repetitiefDNA zijn 
geassocieerd met eenduidige bacteriele virulentie factoren zoals LPS biosynthese enzymen, 
adhesines, glycosyltransferases, ijzer bindingsproteinen, methyltransferase en enzymen 
betrokken bij synthese van fimbriae. De resultaten van deze studie laten zien dat er variatie in 
variable number of tandem repeats (VNTR's) kan bestaan zonder dat er veranderingen 
optreden in het buiten membraaneiwit patroon ofhet AP-PCR patroon. Hiemit concludeerden 
wij dat een starn in staat is gedurende de kolonisatie van de CF long om via toevallige variatie 
in de VNTRs het vimlentie potentieel te moduleren en mogelijkerwijs zelfs aan te passen aan 
veranderende gastheer condities. 
Het microbiologisch analyseren van CF sputum is niet eenvoudig. P. aeruginosa is in staat de 
groei van S. aI/reus te onderdmkken en H. illjluenzae kan gemist worden do.or overgroei van 
P. ael'ugillosa. In hoofdstuk 7 werden zes sputa van verschillende CF paticnten zoweimet 
behulp van routinematige microbiologische kweek technieken ais moieculaire teclmieken 
bestudeerd. Genen voor het bacterieel 16S RNA (small sub-unit ribosomal RNA of wei ssu 
rDNA) werden geamplificeerd met behulp van breed-spectmm primers en de PCR producten 
werden gekloneerd. De hcrkomst van individuele, bacteriesoort specifieke klaons werd 
vervolgens vastgesteld met behulp van hybridisatie en DNA sequencing. Hybridisatie is 
ven'ichtmet twee algemene probes coderend voar gram-pasitieve en gram-negatieve bactericn. 
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Daamaast is gewerkt met drie additionele probes die specifiek zijn voor S. aureus, P. 
aerugillosa en H. influenzae. Van een sputum waren de resultaten van de microbiologische 
kweek en de moleculaire methode volledig overeenkomstig. In de overige vijf sputa werden 
discrepanties betreffende de aanwezigheid van S. aureus en/of H. ilif!uellzae waargenomen. 
Ondanks het feit dat DNA van S. aureus en H. ilif!uellzae in drie respectievelijk vier sputa 
werd aangetoond, konden deze isolaten niet gekweekt worden. Al deze CF patienten hadden 
in hun voorgeschiedenis een S. aureus infectie doorgemaakt maar slechts bij eon CF patient 
werd ooit H. ilif!uellzaeuit het sputum gekweekt. Een aantal klonen die met de gram-negatieve 
probe of met de gram-positieve probe aankleurde maar niet geldentificeerd werden door eon 
vande drie specifieke probes werden verder geanalyseerd doormiddel van sequencing. Hierbij 
werden een aantal potentiele pathogenen, die niet eerder gekweekt werden zoals Escherichia 
coli, Klebsiella plleullloniae en Pseudoll/ollas citronellosis, geldentificeerd. Tijdens het kweken 
van CF sputa worden doorgaans mono-culturen van een van de drie 'klassieke' pathogenen 
gevonden. Echter, de moleculaire data geven aan dat ook andere CF gerelateerde pathogenen 
op dat moment nog aanwezig kunnen zijn. Wij concluderen dat de routine kweektechnieken 
voor de CF pathogenen zijn beperkingen hebben omdat zij frequent falen in het isoleren van 
pathogene bacterien die met de moleculaire teclmieken wei aangetoond kunnen worden en die 
mogelijk klinisch relevant zijn. 
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